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I N T R O D U C T I O N 
2/ ... 
2 • 
Modern concepts of the structure, function and metabolism 
of proteins have evolved painstakingly through the centuries. In 
September, 1772, Rutherford discovered the gas which was later 
named nitrogen by Chaptal in 1790 . The fundamental importance 
of nitrogen in the body was only appreciated after Gay-Lussac 
and Thenard had pioneered chemical procedures for organic analysis. 
Magendie applied this knowledge to dietary constituents and 
concluded that nitrogen was an essential component of the diet. 
His early insight into metabolism was depicted in his view that 
body constituents are continuously being replaced, the rate being 
dependent on the tissue. In 1838 the term"protein" was coined 
by Gerard Mulder for substances containing a basic nitrogenous 
component. 
With nitrogen firmly established as a component of body 
tissues, it became necessary to quantitate nitrogen output relative 
to intake . The concept of balance studies was pioneered by 
Boussingault in 1839 in cows. Voit, a pupil of the outstanding 
chemist Liebig, popularised the use of nitrogen balance techniques 
in man for the study of protein metabolism. He, together with 
Bischoff, established that in long-term experiments in healthy 
experimental subjects, nitrogen intake and output were equal, and 
the individual in these circumstances was said to be in nitrogen 
equilibrium. 
The next phase of investigation was centred around quanti-
tative protein requirements. Based on nitrogen balance studies, 
Voit concluded that the average working man required 118 grams 
of protein per day while Chittenden and others contended that 
50-55 grams of protein per day were required to maintain nitrogen 
equilibrium. The concept of qualitative protein requirements 
evolved slowly. In 1810 the first amino acid, cystine, was 
discovered by Wollaston. Later, it was shown that gelatin, 
while containing nitrogen, was unable to maintain nitrogen 
equilibrium on its own (Bischoff and Voit, 1860). While 
Braconnot in 1820 had released individual ·amino acids from 
protein by acid hydrolysis, it was not until 1900 that Kossel 
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and Kutcher observed the variation of a~ino acid content of 
different proteins. It then became possible for Kauffmann(l905), 
W.illcock and Hopkins (1906) and eventually Osborne and Mendel (1914) 
to show that at least certain of the amino acids are indispensable 
constituents of the diet . The meticulous studies of Rose , 
utilising purified amino acid diets, led to the distinction 
between "essential" and"non- essential" amino acids in 1938 in 
rats and man . This concept provided the info rmation that the 
nutritive value of a protein ~s a function o f its essential 
amino acid content . 
Amino acids have widespread effects throughout the body 
apart from the supply of substrate for protein synthesis . 
Professor S . J . Saunders' laboratory, in which the author worked, 
had long been interested in the control of albumin synthesis . 
Analysis of the plasma aminogram in protein calorie malnutrition 
(PCM) had revealed a specific profile with the depression of 
the branched chain amino acids being a prominent feature (Holt 
et al, 1963; Saunders et al, 1967) . The association of this 
depression with a low plasma albumin was instrumental in stimu-
lating the work to be described in this thesis . A fundamental 
issue arose: do specific amino acids influence albumin metabolism? 
Such information has tremendous potential in the understanding of 
PCM and in the management of patients with hepatic and renal 
failure . 
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The first part of this thesis describes the basic study 
in humans relating dietary protein to aibumin synthesis, albumin 
catabolism and the plasma arninogram. 
Part II and Part III describe the effect of amino acid 
supply on albumin synthesis and cataboli~m respectively in the 
isolated perfused rat liver. Such a system obviates any confu-
sion created by different pools or hormonal responses which occur 
in vivo, and allows specific factors to be more easily tested. 
While this work was in progress it became ' apparent that 
the state of the protein synthetic machinery, namely the 
ribosomes, should be defined in the system utilised in Part II 
and Part III. Such basic knowledge would be helpful in under-
standing any change and at the same time would provide information 
about protein synthesis as a whole rather than albumin synthesis 
alone. Part IV therefore contains the work on ribosomal profiles 
in the isolated rat liver perfusions. 
The review of amino acid pools places in perspective 
current views on the relationship of amino acids to diet, protein, 
body compartments and h o rmones . The principles of the methods 
used and their specific application are described in a separate 
chapter, while the detailed methodology is described in the 
Appendix . 
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REVIEW OF AMINO ACID POOLS . 
6/ ... 
I ntro duction 
Concep ts of amino acid - protein 
ship s have ~dv ~n c e d in the past decade. 
6. 
hormone interrelation-
Reference will be made 
to various aspects of these relationships in future chapters. 
To provide perspective for the work to be described, an attempt 
will be made to review these relationships. 
The processes regulating the hepatic intracellular free 
amino acid content are represented in Figure 1. The pool may 
b e p a rtitioned into "micro pools", which are supplied by amino 
acids from (i) the diet, (ii) other tissues and plasma, 
( iii) protej_n-: catabolism, and ( iv) synthesis of non-essential 
amino acids. On the other hand, amino acids are drawn from the 
pool(s) for (a) protein synthesis, (b) amino acid catabolism, and 
(c) transport of amino acids to the plasma and other tissues. 
Changes in this equilibrium occur in response both to the internal 
metabolic demands of the organism and to external environmental 
influences. Appropriate responses represent co-ordinated and 
highly evolved controlling mechanisms incorporating changes at 
t h e cellular, intercellular and interorgan level . It should be 
emphasised that isolation of any one pathway is impossible and 
in practice could be compensated for by changes in other pathways. 
However, for convenience, components of the system will be 
considered independently . 
Compartmentation . 
There is a growing body of evidence in favour of intra-
cellular compartmentation of amino acids in most tissues of the 
body (Munro and Portugal, 1970; Portugal and Jeffay, 1966; 
Portugal et al, 1970; Green and Lowther, 1959; Garfinkel and 
amino acids 
from 
other sites 
amino acids 
to 
other sites 
----
amino acids 
synthesis of from 
amino acids protein catabolism 
dietary 
I ,---amino acids \V..._---J'V....._ _ _,\V .____,\!,' 
INTRACELLULAR 
POOL 
compartments 
amino ~ protein ~synthesis 
acid 
catabolism 
Figure 1 : PROCESSES REGULATING THE HEPATIC INTRACELLULAR 
FREE AMINO ACID CONTENT 
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Lajtha, 1963; Garfinkel, 1966; Rosenberg et al, 1963; Hider 
et al, 1969; Kipnis et al, 1961; Henriques et al, 1955; Askonas 
and Humphrey, 1958; Hendler, 1965 and Ito et al, 1964) . 
The concept of division of the intracellular amino acid 
pool into "physical" or "functional" compartments has profound 
significance. A fundamental application of the heterogeneous 
intracellular amino acid pool could be the ability of the organism 
to use this as a biological controlling mechanis~. For example, 
in states of protein depletion or stress, amino acids could be 
channelled· into compartments which supply protein more essential 
in the particular circumstances. A further application arises 
from the fact that compartmentation of amino acids is contrary to 
the basic assumption of nearly all techniques designed to measure 
protein synthesis by radioactive isotopes. Protein synthesis 
is frequently estimated from the relationship between the 
specific activity of the precursor amino acid and the radioactivity 
. 
incorporated into the relevant protein . However, if compartment-
ation exists to any degree then it is mandatory for the investigator 
to measure the relevant precursor specific activity . Technically 
this repre~ents a formidable task. 
The relationship between amino acid supply and protein synthesis. 
In 19]6, Addis demonstrated the tremendous loss of liver 
protein on protein deprivation. This has subsequently been 
confirmed and recently extended to specific proteins . Further-
more, Kirsch et al (1968) and James and Hay (1968) have confirmed 
the reduction in albumin synthesis during protein restriction 
inferred by earlier workers (Hoffenberg et al, 1966; Freeman 
and Gordon, 1964) . In vitro, Eagle ' et al (1961), Riggs and 
Walker (1963) and Schingoethe et al (1967) have shown that, 
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within limits, protein synthesis is augmented with increasing 
amino acid supply. Similarly, in perfusion studies of the 
isolated rat liver, both Jefferson and Korner (1969) and John 
and Miller (1969) have shown augmented protein synthesis with 
increased amino . acid supply. In addition, Amenta and Johnston 
(1963) added hydrazine, which increases free amino acid concen-
tration in both blood and tissues (Korty and Coe, 1968; Cornish 
and Wilson, 1968), to their perfusions and were able to increase 
protein synthesis. 
If one continues to supply amino acids above requirements, 
then decreasing proportions of amino acids are incorporated into 
protein (Meyer et al, 1947; Eckhar~et al, 1948). While 
amino acids exert some basic control over protein synthesis, 
there is a great deal still to be learned: do different amino 
acids influence protein synthesis to different degrees? Is 
the response protein specific? What is the mechanism of action? 
While no clearcut answers can be provided , much can be inferred. 
It is pertinent at this stage to review relevant mechanisms 
of protein synthesis. 
The amino acids t'o be used for protein synthesis are 
drawn from the pool of supply (probably extracellular in the 
case of muscle - Hider, 1969), activated on their carboxyl end 
and transferred to their respective transfer ribonucleic acid 
(tRNA) in a series of reactions involving adenosine tri-
phosphate (ATP) and the respective aminoacyl tRNA ligases. 
While the latter enzymes are specific for their amino acids, 
more than one tRNA is available for many amino acids. The 
changed tRNA then places the amino acid in order in the 
peptide chain according to the code specified by messenger RNA(mRNA) 
9 • 
Two tRJ.~A species with different anticodons for the same amino 
acid go to different ooints in the messenger sequence (Weisblum 
et al, 1965). 
The advances in ultracentrifugation, electron microscopy 
and time sequence tracer studies have clarified the basic 
mechanisms of protein synthesis. Claude (1937, 1940) first 
introduced the term "microsomes" which were shown to be wide-
spread in nature (Claude, 1941) and to consist of RNA and 
phospholipid (Claude, 1943). Electron microscopy by Porter 
and Kallman (1952) and Porter (1953) led to the definition and 
naming of the endoplasmic reticulum with its tubules and 
vesicles. Palade and Siekevitz (1956-1960) described two types 
of endoplasmic reticulum according to the presence or absence 
of electron dense particles . In 1958 the term "ribosomes" 
was introduced by Roberts "to designate ribonucleo protein 
particles in the size range 20s to lOOs". Ribosomes have 
become established as the structural support for the series 
of enzymic reactions involved in peptide bond formation and as 
a carrier of the enzymes involved . The ribosome has a protein 
content of 55 - 65% with a high concentration of basic amino 
acids (Cohn and Butler, 1958; Butler et al, 1960) but little 
cystine or tryptophan (Crampton and Petermann, 1959) and 
35-45% RNA. It was found that the incorporation of radioactive 
amino acids was concentrated in the 170s fraction rather than 
the 70-80s fraction while aggregations of ribosomes were 
demonstrated by numerous workers after gentler methods of 
cell fractionation were evolved (Warner et al, 1963; Wettstein 
et al, 1963; Noll et al, 1963; Gierer, 1963; Spyrides and 
Lipmann, 1962). These aggregates were named "polysomes" by 
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Warner et al (1962) or "ergosomes" by Wettstein et al (1963). 
The term polysome is in common usage and is applied to groups 
of five or more ribosomes on a mRNA strand. Polysomes are 
regarded as indicator.; of active protein synthesis although 
Munro et al (1964) showed that single ribosomes are probably 
active if attached to mRNA . 
Ribosomes have two sites to which tRNA binds:. a .n "A" 
site (aminoacyl) which is responsible for the initial binding, 
and a "P" site (peptidyl) to which the tRNA peptide chain is 
transferred. In mammalian cells the presence of chain 
initiation factors (Galper and Darnell, 1969; Reboud, 1969; 
Arnstein and Rahamimoff, 1968; Mosteller et al, 1968; · Smith 
and Marcker, 1970; and PrLchard et al, 1970) is debated, 
while the presence of termination factors is even more uncertain. 
Peptidyl transferase and translocase are found within the ribo-
some. Peptidyl transferase catalyzes the reaction between the 
free carboxyl group of ' the nascent peptide chain on the "P" 
site and an amino group of the entering aminoacyl tRNA on the 
"A" site. Translocase catalyzes the transference of newly 
made peptidyl tRNA from the "A" site to the "P" site. 
In 1961,Birbeck and Mercer suggested that endoplasmic 
reticulum-bound ribosomes and free ribosomes manufacture 
export and intracellular protein respectively. Considerable 
support for this concept has emerged. Thus Redman (1968), 
Takagi and Ogata (1968); and Hi cks et al (1969) found that 
albumin was synthesized chiefly on the endoplasmic reticulum-
bound ribosomes. Ganoza and Williams (1969) reported similar 
findings for all plasma proteins. Ganoza and Williams (1969) 
and Hicks et al (1969) found that free and bound ribosomes 
were responsible for liver c ell sap protein and ferritin 
synthesis respectively. However, Ragnotti et al (1969) found 
that both populations were able to incorporate labelled amino 
acids into cytochrome C reductase of liver microsomes. The 
latter findings have yet to be confirmed·. A rat liver cell 
contains 60% bound ribosomes and 40% free ribosomes. 
Ribosomes are synthesized within the nucleolus (Brown, 
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1966) . However, ribosomal proteins are found in the cytoplasm 
(Lindsay, 1966; Vincent et al, 1966; Mundell, 1967) and are 
probably synthesized on cytoplasmic polysomes (Ogata et al, 1967 
and Terao et al, 1968). The complete ribosome is probably 
assembled within the nucleolus and matures progressively as it 
reaches the cytoplasm (Darnell, 1968). 
The total amount o f deoxyribonucleic acid (DNA) per 
diploid nucleus is considered to be essentially constant at 
-12 7 x 10 grams from one mammal to another and from one tissue 
to another in the same animal (Vendrely, 1955) . This contrasts 
with the RNA constituent where an increase in body size is 
associated with increased RNA synthesis and an increased rate 
of protein synthesis. Therefore with regard to DNA, tissue 
differences are achieved by suppressing part of the informa-
tion contained in the structural gene of the cell so that only 
appropiiate proteins are produced . Gurdon and Dehlinger (1966) 
have shown that even in specialised cells this information is 
potentially available. They showed that when the nuclei from 
the intestinal epithelium of the frog are transferred to an 
enucleated frog ovum, embryonic development still occurred. 
This suggests that cytoplasmic mechanisms regulate the 
expression of nuclear information. It is probably the histone 
fraction of the chromosomes which is responsible for masking 
the remaining DNA template activity. Histones are probably 
synthesized on cytoplasmic polysomes and subsequently trans-
ported into the nucleus (Robbins and Borun, 1967; Gallwitz 
and Mueller, 1969). Histones are basic proteins that have 
been fractionated into three major types : (1) lysine rich, 
(2) moderately lysine rich, and (3) arginine rich (Bonner et 
al, 1968; Kinkade and Cole, 1966; Stellwagen and Cole, 1968; 
Hnilica, 1967) . Their suppressive role can be modified by 
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their interaction with non-histone protein, (Marushige et al, 
1968; Paul and Gilmour, 1968) by phosphorylation and by 
acetylation (Allfrey et al, 1966; Allfrey, 1968). Phospho-
rylation of histones by cyclic adenosine monophosphate has been 
described (Langan, 1968). 
The role of RNA polymerase in the DNA- directed synthesis 
of RNA is well established (Reviews by Haye~, 1967; Martin and 
Tocchini-Valentini, 1967; Charnbon, 1968; Geiduschek and Hasel-
korn, 196 9) . 70-80 % of this rapidly labelled RNA is broken 
down in the nucleus and the remainder probably constitutes rnRNA. 
While Goldstein and Prescott (1968) have shown the rapid 
migration of protein into and out of the nucleus, protein 
particles have been identified in the nucleus associated with 
rap idly labelled RNA which is probably rnRNA . This protein, 
synthesized on cytoplasmic polysomes , could perform the dual 
function of transport of mRNA out of the nucleus and directing 
its association with the appropriate ribosomal population. 
Thus , while the nucleus undoubtedly contains the primary 
information for protein synthesis, the process appears to be 
subject to cytoplasmic feedback control ~echanisms which may be 
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of greater significance than is generally appreciated. 
Protein catabolism. 
The hepatic intracellular amino acid pool is supplied 
mainly by the diet. Buchanan (1961) showed that 70% of rat 
liver protein is replaced every four to five days from dietary 
sources. Reduction of dietary amino acid supply is compensated 
for by an increased utilisation of amino acids from other sources. 
The response by the organism to maintain its hepatic amino acid 
pool size during protein deprivation is a fascinating phenomenon . 
The immediate response appears to be an attempt to maintain the 
status quo with the channelling of amino acids from protein by 
catabolism, decreased catabolism of essential amino acids and 
transport of amino acids from other tissues to the liver. The 
major early compensating mechanism is the increase in hepatic 
protein catabolism. Gan and Jeffay (1967), using a constant 
infusion technique in rats, showed that recycling of amino acids 
from liver protein degradation provides 50% of the free amino 
acid pool of fed rats but 90% of the pool in fasted rats . In 
addition, Stephen and Waterlow (1966), using the differential 
decay rate of the carboxyl relative to the guanido carbon of 
arginine, concluded that normally 50% of arginine liberated is 
re- utilised whereas about 70% is re-utilised for protein 
synthesis on a low protein diet. However, protein degradation 
is poorly understood, not only at the control level but even 
the basic mechanisms - that is the site, and the physico-
chemical reactions involved. Current concepts will be reviewed 
briefly at this stage . 
Most proteins are degraded according to first order 
kinetics . Once formed they have a random chance of degradation. 
The molecule could be considered to be in equilibrium in a 
number of forms and only certain configurations are liable to 
degradation. Normally, the majority of molecules are in a 
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state resistant to degradation. Increased susceptibility to 
degradation could be induced "by interaction with small molecules, 
similar or dissimilar peptides and subunits or by association 
with various intracellular organelles" (Schimke, 1970). A 
degradation system(s) with its relevant features is shown in 
Figure 2. 
Altered or denatured proteins are more readily degraded 
than are "native" proteins. (Green and Neurath, 1954; 
Linderstr¢m-Lang, 1950). The conformational change involved 
would depend on the type of peptide bond exposed, specificity 
of the system or interaction with other molecules. This is 
exemplified by the following examples : Markus (1965) has shown 
that, while the binding of methyl orange to albumin causes no 
change in sedimentation or optical rotatory dispersion properties, 
it materially inhibits the proteolytic degradation of albumin. 
Similarly, Mazur and Shorr (1950) have shown that purified 
ferritin with a high iron content is less susceptible to inacti-
vation by proteolysis than is ferritin with low iron content. 
Also, tryptophan stabilizes tryptophan pyrolase to trypsin inacti-
vation particularly when the enzyme is completely conjugated 
with haematin (Schimke et al, 1965a) . . According to Schimke (1970) 
"the concept that the rate of degradation of a protein is 
determined by the properties as a substrate for a non-specific 
degradation system is supported by studies with various enzymes 
and cell organelles''. Thus, irrespective of dietary intake 
(8~70% protein), degradation (expressed as a first order constant 
or half-life) is constant for many proteins, e.g. arginine 
PROTEIN DEGRADATION MECHANISM 
\I 
conformational change 
\:/ 
altered protein 
I 
I 
1· 
I 
I 
. 
Figure 2: PROTEIN . DEGRADATION SYSTEM 
specific/ non specific 
constant /varying rate 
mechanisms 
1. activation of 
enzymes · 
2. synthesis of 
protein 
3. transport 
4. organelle 
structure 
integrity 
enzymes involved 
-" 
·' 
1. lysosomal acid 
proteases 
2. other proteolytic 
enzymes 
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(Schimke, 1964), xanthine oxidase (Rowe and Wyngaarden, 1966), 
total mitochondrial protein (Swick et al, 1968) and total liver 
protein (Schimke et al, 1964). 
The site of conformational change may differ from the 
site of degradation. This may be in a different organ or 
organelle depending on the protein or the conditions, and thus 
transport may constitute another regulatory site. The 
degradation system may be specific for a particular protein or 
non-specific. In normal circumstances it would operate at a 
constant rate so that the fractional catabolic rate would remain 
constant but the , absolute rate would depend on the magnitude of 
the protein pool. However, as will be discussed in a later 
chapter, with respect to albumin, the fractional rate can change 
as well in certain conditions. The factor involved in this 
change is unknown but it is probably mediated by hormonal changes 
and the response dependent on the tissue involved. 
The mediator of the conformational change could operate 
by activation of an enzyme, increasing enzyme protein synthesis, 
transport of the substrate (protein) as already mentioned or 
change in the structural integrity of the organelle involved. 
It is possible that all these mechanisms may be operative to 
different degrees depending on the protein. In the tadpole, 
inhibitors of protein synthesis were shown to prevent a response 
of acid protease to thyroxin which normally occurs in the 
process of metamorphosis (Weber, 1967), while the glucocorticoid-
induced collagenolytic and proteolytic activity in the skin were 
blocked by puromycin and actinomycin (Houck et al, 1968). 
Degradation of intracellul~r protein is inhibited by agents that 
inhibit energy production (Simpson, 1953; Steinberg and Vaughan, 
1 6 • 
1956) . This has been re-evaluated by Brostrom and Jeffay (1970) 
who showed that the action of several types of inhibitors, inclu-
ding energy or respiratory inhibitors, is dependent on the level 
of tissue integrity. They concluded that "there may be a 
structural component involved in protein catabolism, the 
integrity of which requires metabolic energy, while the enzymes 
involved in the actual degradation of proteins probably do not 
have an energy requirement". The lysosome system has been 
implicated in a number of catabolic process·es ! While steroids 
stabilise lysosomes, progesterone increases their breakdown 
(Weissman and Thomas, 1964). Lysosomal acid proteases are 
probably involved in tail metamorphosis in amphibians (Weber,1 967), 
the increased turnover in muscle proteins in hereditary muscular 
dystrophy of mice (Tappel et al, 1962), the increased degradation 
involved in vivo (Ashford and Porter, 1962; Deter and de Duve, 
1967) and the increased protein degradation obtained when 
glucagon is added to fluid perfusing rat livers (Green and 
Miller, 1960; Miller, 1961). However , proteolytic enzymes 
with properties, pH optima and distribution different from the 
cathepsins of lysosomes have been described in the brain, 
(Marks and Lajtha, 1963, 1965), kidney and liver (Fruton, 1960; 
Green and Neurath, 1954; Smith, 1951.) On the other hand, 
tissue inhibitors of protease activity have been reported by 
Finkenstaedt (1957) and Blackwood and Mandl (1964). The 
mechanism and control of degradation can be seen to be highly 
speculative at this stage. It has been common to draw 
conclusions from "liver protein" experiments which may be · 
different from changes in other tissues. Furthermore, 
examination of large populations of proteins may mask changes 
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in individual proteins. Degrees of degradation undoubtedly 
exist and not only protein molecular integrity but also 
functional activity and possibly immunological reactivity should 
be assessed. Thus Schimke et al (1965b) showed that enzyme 
activity and immunological reactivity may ·not necessarily be 
lost together. He found that tryptophan pyrrolase activity was 
lost, while immunological properties 'Were retained following 
degradation in crude homogenates. 
Despite the lack of basic knowledge in this field, the 
contribution of protein catabolism to the amino acid pool is 
established. This is hardly surprising when one considers that 
the total free amino acid content of tissues is 15-30 millimoles 
while the protein-bound amino acid concentration is 60-120 times 
this quantity. A small change in protein catabolism can there-
fore bring about a vast change in the intracellular free amino 
acid concentration. Interplay of protein catabolism and diet 
is well illustrated by the work of Munro and his colleagues. 
In vitro all amino acids (except isoleucine) were shown by 
Baliga et al (1968) to be essential for ribosomal aggregation. 
In vivo only tryptophan became limiting, the other amino acids 
being supplied by protein catabolism. However, when recycling 
of amino acids is reduced by protein restriction, other amino 
acids as well as tryptophan were shown by Pronczuk et al (1969) 
to be limiting to ribosomal aggregation. An important 
corollary arises : to what extent can control of protein 
catabolism be a regulating mechanism of a protein synthesis and, 
more basically, what .controls protein catabolism? 
Amino acid synthesis and catabolism: 
In 1937 Braunstein and Kritzman discovered the 
transaminases which play a major role in the transfer of 
nitrogen between compounds. On the other hand,the work of 
Rose (1938) established that the body is dependent on the 
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diet for certain "essential" amino acids. Those amino acids 
found to be "essential" for man are tryptophan, lysine, leucine, 
isoleucine, valine, phenylalanine, threonine and methionine. 
The rat has similar requirements although, in addition, 
histidine and arginine are required, The "non essential" 
amino acids can be synthesized by the body if substrate is 
provided. 
Degradation of amino acid offers a rapid means of 
controlling tissue amino acid concentrations. The effect of 
hydrazine in raising tissue levels of amino acid by inhibiting 
transamination has already been described. Miller (1962) has 
shown in perfusion studies that the liver is required for 
degradation of arginine, histidine, lysine, methionine, phenyl-
alanine, threonine, tryptophan and tyrosine. The branched chain 
amino acids are degraded chiefly at extra hepatic sites. Thus 
Ichihara and Koyama (1966) found high concentrations of specific 
transaminases in heart, kidney and skeletal muscle and very much 
smaller concentrations in liver. In addition, perfusion of the 
isolated rat liver has shown a fall or no change in most amino 
acids while the branched chain amino acid concentrations have 
risen progressively (Schimassek and Gerek, 1965; Fisher and 
Kerly, 1964). 
Hankes et al (1967a, 1967b) and Daniel and Waisman (1969) 
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demonstrated that an increased amino acid intake is associated 
with increased degradation of that amino acid. By measuring 
rat liver enzymes involved in amino acid metabolism under 
increasing protein intakes, Harper (1968) has concluded that 
enzymes involved in the metabolism of non~essential amino acids 
undergo adaptation related to the amount of protein consumed, 
while enzymes for catabolism of essential amino acids adapt to 
dietary protein levels as they relate to the needs of the body. 
In support of this concept is the work of McFarlane and von 
Holt (1969) who found that the oxidative degradation of leucine 
and phenylalanine markedly decreased on a 2% casein diet whereas 
glutamate and alanine were unaffected. 
The unique role of dietary tryptophan in vivo in relation 
to protein synthesis is possibly related to the complex changes 
in its degradative enzyme, tryptophan pyrrolase, brought about 
by a meal. Thus the work of Knox (1951), Knox and Mehler (1951), 
Civen and Knox (1959), Lee (1956), Dubnoff and Dimick (1959), 
Schimke et al (1964 and 1965a), Knox et al (1966) and Greengard 
and Feigelson (1961a, 1961b, and 1962) have established that 
tryptophan pyrrolase is stabilised by its substrate tryptophan 
and induced by glucocorticoids. This once again highlights the 
basic amino acid-protein~hormone relationships. 
Amino acid transport and interorgan flux. 
The work of Christensen (1966, 1968) has done much to 
clarify amino acid transport across the cell. Using Ehrlich 
ascites tumour cells,he has shown that amino acids are trans-
ported in groups according to their structure. Each group 
probably has a specific carrier protein. Amino acids from 
the same group may inhibit one another or in some cases 
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stimulate transport of another group by an exchange mechanism. 
This is contrary to the data of Schafer and Jacquez (1967) who 
showed competit ive stimulation of the transport of some free 
amino acids into ascites tumour cells by others probably 
unrelated to the "exchange mechanism". Similar mechanisms 
are probably responsible for transport out of cells and the net 
effect probably depends on the balance between influx and 
efflux in relation to other intracellular processes already 
described. 
Twenty amino acids are commonly found in proteins. 
However, alanine, glutamine and glutamic acid, and glycine 
constitute 80% of the total free amino acid pool. While these 
four amino acids are probably chiefly responsible for amino 
nitrogen transport between organs, the plasma proteins may play 
a limited role by virtue of their widespread degradation. Felig 
et al (1969) consider that the amino nitrogen resulting from 
peripheral degradation reactions is probably transported to the 
liver mainly in the form of alanine. 
One of the most striking actions of some hormones is 
their effect on plasma and tissue amino acid levels. It is 
frequently difficult to determine their specific action on 
trnnsport as the net effect could well be a result o f the 
action on transport, synthesis of amino acids and protein and 
degradation of amino acids and protein. Furthermore, one 
process may trigger another: elevated amino acids definitely 
increase certain. hormonal levels (Cochrane et al, 1956; Floyd 
et al, 1966; Knopf et al, 1965; Parker ·et- al, 1967; Cremer 
et al, 1968; Munro and Mukerji, 1962; Munro et al, 1965). 
On the other hand, Noall et al (1957) suggested that hormones 
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trigger protein synthesis in target organs by increasing 
flow of amino acids to that organ. No attempt will be made 
to review the effect of hormones on protein synthesis but 
instead, keeping to the central theme of this review, the 
effect of hormones on interorgan amino acid fluxes are illustra-
ted in Figure 3. 
Cortisone or cortisol increases the levels of amino 
acids in muscle (Kaplan and Shimizu, 1963; Ryan and Carver, 1963; 
Betheil et al, 1965} but this appears to be due to decreased 
muscle protein synthesis (Kostyo and Redmond, 1966). Noall et 
al (1957) found that a few hours after intravenous administra-
tion of hydrocortisone,the transport of alpha amino isobutyric 
acid into the liver was increased. Weber et al (1965) found 
that steroids increased the level of free amino nitrogen in 
the liver of feeding rats, while Betheil et al (1965) found 
that this increased only glutamic acid, aspartic acid and 
alanine. 
Thyroxine increased the levels of all amino acids in 
the liver whereas in the carcass only the concentration of 
histidine, lysine and tryptophan were significantly increased. 
(Wellers and Leblanc~ 1966). Both cortisol and thyroxine 
mobilise amino acids from muscle to the liver but the difference 
in amino acid concentrations finally achieved is probably due 
to differing actions of cortisone and thyroxine on the amino 
acid pathways . Noall et al (1957) found that growth hormone 
increased the pe~etration of alpha amino isobutyric acid: in 
all tissues except cardiac muscle. 
Mondon and Mortimer (1967) have shown that during 
tissues especially 
muscle 
thyroxine Jr insulin ,; 
cortisone growth hormone '-
I 
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j I glucagon-< -· 
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diet 
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hormone release 
Figure 3: INFLUENCE OF HORMONES ON INTERORGAN 
AMINO ACID FLUX 
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perfusion of the isolated rat liver, insulin decreased the 
release of amino acids into the perfusate, probably due to 
decreased protein degradation. Sanders and Riggs (1967) have 
demonstrated increased penetration of ·model amino acids into the 
liver following insulin administration. This appears to be 
secondary to other changes. Wool (1964) found that insulin 
results in accumulation of only six amino acids within muscle 
despite t he reduction in all plasma amino acids. Wool and 
co-workers (Castles and Wool, 1964; Scharff and Wool, 1965; 
Wool and Scharff, 1968) have suggested that protein synthesis 
removes the others too rapidly to allow their accumulation. 
While thyroxine and cortisone mobil~se amino acids 
from the muscle (Fig.3), glucagon appears to have this effect 
on liver. On the other han~ cortisone, insulin and growth 
hormone increase amino acid transport into the liver while 
the latter two hormones have the same effect on muscle . 
The response of the body is probably a sequential 
response with initially glucagon increasing hepatic protein 
catabolism and augmenting the diet by increasing the intra-
cellular hepatic amino acid pool. Insulin then decreases 
catabolism and increases penetration of amino acids into 
muscle and, more sluggishly, into the liver. In a post-
absorptive phase cortisone probably mobilises amino acids 
from the carcass to the liver. In a fasted state glucagon 
levels are increased and this may represent the attempt by the 
body to maintain the hepatic intracellular amino acid pool. 
However, tryptophan is still limiting to protein synthesis 
(see before) in the circumstances. The increased amino acid 
levels in the liver are wasted in the absence of sufficient 
tryptophan; glucagon levels therefore decline after forty-
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eight hours of fasting. The balance between the hormones 
and their interaction with diet may be fundamental in controlling 
basic aspects of protein metabolism. It is interesting to note 
the degradation rates of hormones by the liver (Figure 4), which 
in conjunction with other tissues, further modifies hormone 
levels. From this Figure it can be seen that insulin and gluca-
gon are rapidly degraded by the isolated rat liver (Kelman et al, 
1971) while parathyroid hormone, proinsulin and growth hormone 
are degraded very slowly. Albumin degradation is shown for 
comparison. This proposed response is probably an over-
simplification but it is an attempt to emphasise the complex 
control of the hepatic intraceliular amino ac-id pool. Emphasis 
has been placed on the liver but control takes place at all 
levels of cellular and organ function. 
The influence of diet. 
The daily intake of each amino acid in dietary protein 
is many times greater than the pool of the corresponding free 
amino acid. In 1912 van Slyke and Meyer showed that the 
response to a meal of protein was characterised by an increase 
in the plasma amino Pitrogen. If one essential amino acid is 
present in relatively low concentration in the dietary protein, 
it will tend to be removed by the tissues as rapidly as it is 
absorbed. In these circumstances, the limiting amino acid of 
dietary protein is indicated by the lowest rise of an amino acid 
in the plasma relative to requirements of the animal (Longenecker 
and Hause, 1959, 1961; Longenecker, 1963). This was confirmed 
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in man by Yearick and Nadeau (1967). The portal blood response 
to dietary protein is up to five times that of the peripheral 
blood (Denton et al, 1953; Denton and Elvehjem, 1954; Ganapathy 
and Nasset, 1962; Porter and Williams, 1963; Peraino and 
Harper, 1963; Elwyn, 1966). Similarli, the portal blood 
amino acid concentration in general reflects that of the 
dietary amino acids (Denton and Elvehjem, 1954; Goldberg and 
Guggenheim, 1962; McLaughlan et al, 1963; Pion et al, 1964; 
Buraczewski et al, 1967). However, Elwy~ (1968) has shown that 
the exchange of nitrogen between aspartate, glutamate, glutamic 
acid and alanine takes place at gut level . Thus very little 
glutamine or aspartate but high concentration of alanine and 
ammonia are present in portal blood. In addition, while 
glutathione is absent in the diet, large amounts of it appear 
in portal blood and this accounts for more cystine and glutamic 
acid than appears as free amino acids . Thompson et al (1950) 
have shown that most essential amino acids in liver, muscle 
' 
and spleen are decreased in the rat on a protein-free diet . 
. 
In all tissues histidine and arginine were increased,while in 
liver and muscle threonine was increased. Wiss and Krueger 
(1949) and Wiss (1949b) also showed the reduction of the 
essential amino acids and the increased histidine levels. 
Under conditions of protein restriction in rats (Wiss, 1948, 1949a; 
Henderson et al, 1949), dogs (Lo~genecker, 1961) and pigs 
(Richardson et al, 1965) the plasma essential amino acids are 
reduced, except for histidine and lysine. In man (Tuttle et 
al, 1962; Swen~eid et al, 1966, 1968; Adibi, 1968) similar 
changes occurred. In rats (Wiss, 1949a) and man(S~en~eid et 
al, 1963, 1966, 1968; Young and Scrimshaw, 1968) the non-
essential amino acids were increased or remained constant, 
while in kwashiorkor in children (Holt et al, 1968) similar 
changes were found. The study of the effects of different 
diets on amino acid pools is fraught with problems, apart 
from trying to separate the part played by the different 
contributions to the pool. Decreased amino acid intake or 
the administration of imbalanced amino acid diets leads to 
falling off of appetite which can be reversed by supplying the 
missing amino acid directly to the blood supply of the brain 
(Leung and Rogers, 1969). Pair feeding would seem the logical 
control. Unfortunately this results in the control animals 
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consuming all their food in a short space of time and one is 
therefore dealing with a fasted control and a fed experimental 
animal. Forced feeding, which is the other alternative, is 
associated with metabolic changes (Sidransky and Farber, 1958; 
Sidransky and Verney, 1964; Sidransky et al, 1964; Staehelen 
et al, 1967). These include increase in liver size, uptake of 
amino acid into protein and increased RNA content with the shift 
of polysomes towards heavier classes. The reverse occurs in 
muscle. Wagle and Sidransky (1965) have shown that adrenal-
ectomised rats on cortisorestill show this response and Leon 
et al (1965) have shown that physical stress applied to 
adrenalectomised rats still results in an increased capacity 
for protein synthesis. 
The administration of high protein diets is associated 
in infants with elevated plasma amino acids, especially the 
branched chain amino acids, with no change in growth rates (Holt 
et al, 1968; Snyderman et al, 1968). In rats, high protein 
diets led to increased levels on the first day of the diet 
but thereafter levels decreased to normal range, except for 
the branched chain amino acids (Anderson et al, 1968). 
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PRINCIPLES OF METHODOLOGY. 
28/ ... 
28. 
ALBUMIN SYNTHESIS 
Introduction 
The introduction of radioactive isotopes offered new 
opportunities for quantitative measurements of protein 
metabolism. Nitrogen balance studies were gradually super-
seded by kinetic measurements of the individual protein. 
Until recently, the standard method of measuring 
albumin synthesis was to derive synthesis from catabolic studies 
in nutritional equilibrium, when synthesis was presumed to equal 
catabolism. This suff red from the drawback of having to 
! 
derive synthe~is1 over long periods of time and, more limiting, 
to be dependent on steady state conditions. Another approach 
was that of Grossman et al (1960): total body half-life of 
(1 31 r) albumin provides a measure of the fraction of total body 
pool catabolised per day. The extra- to intra-vascular ration 
of the protein applied to total body catabolism provides a 
measure of the true fraction of intra-vascular protein 
catabolised per day. However, plasma half-life represents 
I 
both catabdlism of labelled molecules and dilution of l~belled 
pools by unlabelled, newly synthesized molecules. The 
difference between the two fractional values provides a measure 
of synthesis. Problems arise with the accurate measurement of 
pool sizes, the time required and the fact that the pool must 
either remain constant or be remeasured frequently. Matthews 
(1961) proposed a method for measuring albumin synthesis and 
transfer rates of albumin molecules from the extra-vascular 
compartment. However, the indiv~dual contributions to the 
"synthesis plus transfer rate" cannot be accurately quantitated 
although approximate values can be obtained by means of an 
analogue counter. 
Most estimates of the synthesis rat~ of proteins are 
based on the precursor - product principle. Labelled amino 
acids are used and an estimate of synthesis is obtained by 
the ratio of protein-bound radioactivity relative to free 
labelled amino acid at the site of protein synthesis, i.e. 
where 
M R Equation 1. = a. 
M = Mass of protein synthesized. 
R = Radioactivity incorporated into protein. 
a = Mean specific activity of the amino acid. 
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The main problem is the accurate measurement of the precursor 
amino acid specific radioactivity at the site of protein 
synthesis. The radioactivity achieved in the protein is 
dependent on the rate of inc9r.poration of the labelled amino 
acid into the protein. This in turn depends on the proportion 
of labelled amino acid relative to the total concentration of 
that amino acid in the precursor pool. The latter is subject 
to numerous variables: the dose of labelled amino acid 
administered, the blood flow to the organ, transport across 
the cell membrane, intracellular compartmentation, synthesis 
and degradation of amino acids, catabolism of protein a.:i.d 
supply of unlabelled amino acids (Figure 5). The variables 
are enormous - not only from condition to condition, but also 
from individual to individtial and from one period to another. 
It is therefore clear that the precursor specific activity must 
be measured . Plasma amino acid specific activities are 
worthless, while serial biopsies for the precursor specific 
activity are impractical. The next logical development was 
diet 
unlabelled protein 
catabolism 
synthesis 
transport 
compartmentation 
unlabelled : labelled 
amino acids I amino acids 
I 
I 
PRECURSOR AMINO ACID POOL 
catabolism 
synthesis 
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(albumin) 
Figure 5: FACTORS INFLUENCING THE PRECURSOR 
AMINO ACID SPECIFIC ACTIVITY 
isotope dose 
blood flow 
catabolism 
a means of estimating the intracellular precursor activity. 
However, to be effective, it had to be possible to sample 
this easily and at least at two points in time to obtain a 
measurement of rate of synthesis. This is only practical 
in tissue culture or cell free systems. · 
It therefore became imperative to find an extra-
cellular indicator of intracellular events. Hippurate was 
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tried as an indicator of glycine precursor pool specific radio-
activity but this approach proved to be fraught with problems 
(Weismann et al, 1961). 
In 1946,Delluva and Wilson demonstrated that 14co 2 
combines with endogenously produced ammonia and ornithine in 
the liver to form arginine labelled only . in the guanidine 
carbon atom. The arginine may then be used for albumin 
synthesis while the guanidine c~rbon of arginine may be 
cleaved off by the action of arginase to provide the urea 
. 
carbon atom (see diagram of Krebs-Henseleit cycle, Figure 6). 
Swick (1958) fed rats a diet containing calcium (14c) carbonate 
and compared the final specific activity of urea and of liver 
protein arginine guanidine carbon. Because of the close 
relationship between guanidine carbon of arginine and the 
carbon of urea, he suggested that urea released from the 
liver be used as an indicator of the specific activity of the 
guanidine carbon of intracellular arginine. Both McFarlane 
(1963a) and Reeve et al (1963) independently defined the 
principles of the system and established the technique known 
as the (14c) carbonate technique for liver-produced plasma 
protein synthesis. 
The impetus given to the investigation of albumin 
metabolism by the work of Delluva and Wilson, Swick, McFarlane 
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and Reeve et al has been enormous. Equipped with tools for 
simultaneously measuring synthesis and catabolism independently, 
the investigator is able to separate and identify the respective 
controlling mechanisms! 
An alternative . method of measuring protein synthesis 
directly is based on the principle that if a labelled amino 
acid is infused continuously, a constant plateau precursor 
specific radioactivity will be achieved, the level depending on 
conditions and the tissue examined (Waterlow and Stephen, 1968 
and Gan and Jeffay, 1967). This technique has a number of 
disadvantages: the plateau specific radioactivity must be 
defined for each condition and tissue, the tissue must be 
sampled, albeit only once, after the plateau has been defined 
and relatively large doses of isotope must be used. This 
technique is therefo~e unlikely to achieve application in 
humans. 
Principles of the method. 
Essentially, the method depends on a comparison of 
total activities and total masses of carbon incorporated into 
two products of the same precursor in a given time. 
Equation 1 can be rewritten 
R 
M a . = Equation 2. 
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If more t han one product is derived from the same precursor then·-
a = 
R 
a 
"M 
a 
In the case of the (14c) carbonate technique 
R albumin 
M albumin = 
R urea 
M urea 
Equation 3. 
Equation 4. 
where M albumin= the mass of albumin guanidine carbon synthesized 
M urea = the mass of urea carbon synthesized 
R albumin = total activity in albumin arginine guanidine carbon 
R urea = total activity in urea carbon. 
The method has been mathematically defined by Reeve et al (1963) 
and Reeve (1965). Figure 7 depicts the system in a simplified 
form. The common precursor pool is shown to consist of units 
each emitting 10 counts per minute. For each molecule of argin-
ine in albumin or of urea synthesized, one unit of precursor is 
depicted as being utilized. 
Therefore 
mass o f albumin 
mass of urea = 
padioactivi ty of albumin 50 = 5 
radioactivity of urea i.e. 20 2 
Thus the absolute rate of albumin synthesis may be obtained if 
the total activity incorporated into the two products and the 
absolute rate of urea synthesis are known. 
This system is shown in Figure 8. The four basic 
precursor pool {in cpm) 
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Figure 7: PRINCIPLE OF THE CARBONATE METHOD 
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components of the system include (1) the urea system, 
(2) the arginine system, (3) the albumin system, and 
14 (4) the ( C) label. 
The urea system. 
Bollman et al (1924) demonstrated that urea is largely 
synthesized in the liver. The finding of arginase activity 
in the brain, skin, plasma, kidney and intestine implied that 
urea could be formed at a site other than the liver. This 
would negate one of the basic_ prerequisites of the method that 
both urea and albumin synthesis occur at the same site. 
Tavill et al (1968) found essentially no urea synthesis extra-
hepatically while Kornberg et al (1952) concluded that in cats 
2% of total urea synthesis could result from extrahepatic urea 
synthesis. For practical purposes therefore, urea is 
synthesized exclusively in the liver. 
After synthesis in the liver, urea diffuses rapidly into 
the plasma and then throughout the body water. The body water 
urea is either broken down by the gut or excreted in the urine. 
From Equation 4 it is apparent that two measurements in the 
urea system are required: 
(1) the mass of urea produced, and 
(2) the radioactivity achieved in urea. 
Koj et al (1964) suggested that the mass of urea synthe-
sized could be obtained from the product of the fractional 
rate of urea synthesis and the body urea pool. However, 
Regoeczi et al (1965) showed that inaccuracies existed in the 
measurement of the size of the body urea pool, while the 
assumption, on which this method depends, that the urea is 
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present throughout the body water at the same concentration 
as in the plasma, is invalid. McFarlane et al (1965) 
therefore suggested a modified formula substituting specific 
activities for ·total activities by dividing both sides of 
Equation 4 by the sizes of the urea carbon and guanidine 
carbon pools. The following formula is thus obtained: 
34. 
FSR albumin 
FSR urea = 
SA albumin at time t .... Equation 5. 
SA urea at timet 
This can be rearranged: 
FSR albumin= FSR urea X SA albumin at t SA urea at timet 
Where FSR = fractional synthesis rate 
SA = specific activity. 
Equation 6. 
In a closed system this specific activity at time t 
can be replaced by the maximum specific activity reached. 
However , in vivo losses of urea occur during measurement as 
shown in Figure 8. By extrapolating the curve of plasma 
urea specific activity to zero time, a hypothetical maximum value 
for (14c) urea specific activity can be obtained before losses 
have time to occur. Howeve.r, extrapolation does not give an 
~xact result as neither slow arrival of ( 14c) labelled 
molecules in the plasma nor the continuing synthesis of ( 14c) 
urea is taken into account. The.refore Koj and McFarlane (1968) 
have suggested the use of ( 13c) urea slopes. The ( 13c) urea 
curve is essentially a single exponential and the hypothetical 
maximum urea specific activity can be obtained by multiplying 
13 the area of a plasma slope of the ( C) urea by the area 
measured under the ( 14c) urea specific activity curve plotted 
on linear paper. However, this "area method" assumes that 
equilibration between plasma and extra-vascular urea is so 
rapid that newly synthesized ( 14c) urea can be regarded as 
being almost instantaneously distributed throughout the 
body urea pool. Jones et al (1968) have shown that this 
is not the case and that the plasma slope consists of two 
exponentials indicating at ·1east two body compartments . 
In spite of this, more accurate corrections have yet to be 
proposed in this system. 
Similarly, the fractional synthesis rate of urea 
13 is more truly represented by the ( C) urea curve than by 
14 the ( C) urea curve due to the continue~ incorporation 
14 
of the ( C) label into hepatic arginine with subsequent 
continuous release of labelled urea resulting in reduced 
14 slopes. The use of the endogenously produced ( C) urea 
therefore results in underestimation of the fractional 
synthesis rate and maximum specific activity of urea. 
The arginine system . 
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While it is clear that hepatic intracellular arginine 
can be derived from numerous sources such as diet, plasma, de 
novo synthesis and protein catabolism, little is knovnof the 
origin of arginine used for urea and protein synthesis . · rt 
is conceivable that significant compartmentation exists (see 
review of amino acid pools) and that arginine specific 
activity at the ribosomal level may differ from that at a 
level of the Krebs - Henseleit cycle activity. It is unlikely 
that subcellular fractionation will solve this problem 
and it remains as a basic assumption of the method. 
The albumin system. 
Albumin is synthesized exclusively in the liver. 
However, unlike urea which appears in the blood almost 
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irmnediately after labelling, labelled albumin only appears 
in the blood after twenty to thirty minutes due to the 
time taken for peptide chain synthesis and release. Release 
continues for some time, depending on the system. In the 
meantime,labelled albumin, like the unlabelled albumin, is 
subject to both distribution throughout the extravascular 
space and to catabolism, probably at numerous sites (see 
review on amino acid pools.) Labelled albumin then starts 
to return to the intravascular space while the labelled 
arginine derived from albumin catabolism can either be 
reincorporated into protein throughout the body or be broken 
. 
down to urea by arginase. This complex dynamic system 
presents problems to the application of the ( 14c) carbonate 
technique : 
(1) The asynchronous appearance in the plasma of urea and 
albumin would suggest that a correction factor should be 
applied. For example, final urea radioactivity should be 
measured at time t while final albumin activity should be 
measured at t + 30 minutes. In practice, provided the 
time for release is short relative to total experimental 
time, this adjustment can be ignored. 
(2) Originally,ad hoc corrections were applied for the 
distribution and catabolism of albumin . 
to take into account individual variation. 
However, this fails 
131 Instead ( I) 
labelled albumin is given with the ( 14c) label and the fall 
in iodoalbumin is used to correct the ultimate (14c) activity. 
However, this correction ignores the fact that (14c) albumin 
is continuously being released from the liver during the 
early part of the experiment. A more valid correction would 
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therefore utilize an area method similar to urea correction 
or the use of a computer which would simultaneously take 
into account release; distribution and degradation . 
(3) The release of labelled arginine as a result of albumin 
degradation appears to be of little significance despite 
the potential for reincorporation of ( 14c) arginine into 
albumin or the production of labelled urea. Swick has 
stated that 0 the precursor pool of free arginine is always 
composed of newly synthesized material" and is small relative 
to the rate of protein synthesis, while it has been shown 
that extrahepatic urea production is negligible, and the 
quantity of arginine returning to the liver and potentially 
available for urea production must be minute. 
14 The ( C) label. 
The arginine precursor p9ol can be labelled either 
by the injection of ( 14c) carbonate or (6- 14c) arginine . 
The former has a number of advantages : 
(1) Gamma globulin is less highly labelled and therefore the 
potential problems of contamination are less during isolation 
of albumin . 
(2) A longer half-life of ( 14c) albumin relative to (131 r) 
albumin occurs with (6 - 14c) arginine but not with ( 14 c) 
carbonate adrn.Lnistration. This implies that the (14c) 
carb o nate method avoids the recycling of guanidine carbon 
or arginine in liver cells which occurs with the alternative 
method. 
(3) The ( 14c) carbonate label excludes radiation hazard by 
' 
minimal labelling of carcass protein. 
(4) It also reduces potential errors introduced by extra-
hepatic arginase, and most important 
(5) t he effective synthesis interval of protein is shorter 
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and errors which arise in synchronising the synthesis of 
labelled protein with that of labelled urea in the liver tend . 
to be reduced. 
The major disadvantage of ( 14c) carbonate is the 
lower activities achieved in the albumin labelling. 
Reeve and McKinley (1970) recently proposed the use 
of the arterial (14c) co 2 as an indicator of intracellular 
arginine specific activity . They based this proposal on 
the rapid equilibration of intracellular co 2 and the 
observation by Kornberg et al (1952) that after intravenous 
injection of. ( 14c) bicarbonate,the average specific activity 
of newly synthesized urea was equal to the average specific 
activity of arterial total ( 14c) co 2 and to the expired 
(14c) CO 2 . The chief advantage of the arterial total 
(14c) co 2 method is the avoidance of problems of measuring 
maximum ( 14c) urea specific activities and the urea 
fractional synthesis rate and also the problem of a 
constant rate of urea synthesis . 
The assumptions of the method as used by the author may 
be summarised as follows : 
(1) The arginine specific activity at the sites of urea and 
albumin synthesis is identical . 
(2) Urea and albumin synthesis remain constant throughout the 
experimental period. 
(3) Corrections for continued liberation, distribution and 
degradation of labelled products are accurate. 
The first two assumptions are common to all investigators. 
The ( 14c) carbonate technique has been utilised 
by the author for (a) a human stud~, and (b) a liver 
perfusion study. 
Human study. 
The formula used in this study is as follows 
39. 
F.S.R. Albumin_ = F.S.R. urea x albumin S.A. at t 0 E t· - .. qua ion urea S.A. at t 0 7 
Where albumin S.A. at t 0 = Specific Activity of the guanidine 
carbon of arginine in albumin at 
zero time. 
The absolute synthesis rate of albumin (mg/24 hrs) formula 
Albumin synthesis rate= F.S.R. albumin x intravascular 
albumin pool .... Equation 8 
The fractional synthesis rate of urea was obtained 
from the semilog plot of the prelabelled ( 14c) urea adminis-
tered the day following the experiment. The author used 
this technique for three reasons : 
(1) (13c) urea injection on the day of experiment was · 
precluded through lack of facilities. 
(2) To overcome the defect of the reduced slopes obtained 
14 with endogenously produced ( C) urea due to continued 
incorporation of ( 14c) label into urea. 
(3) To enable a slope to be obtained accurately under 
conditions of minimal urea production as in protein 
depletion. To obtain meaningful results by conventional 
methods of using 5-6 samples over 6 hours, the larger 
volumes of blood required would seriously have influenced 
the intravascular pool size. 
The author is aware that utilising (14c) urea the 
day following the experiment is not ideal and, while 
probably providing a reasonably accurate assessment of 
urea synthesis, suffers from the assumptions that the same 
metabolic conditions prevail on both days -and that the 
labelled urea is not subject to continuous release from the 
liver and distribution throughout the body water. Both of 
these assumptions are not entirely tenable, but the degree 
of error introduced by them is probably not great . 
experimental circumstances the same conditions were 
maintained. 
In all 
The albumin specific activity at was obtained 
to 
by measuring the value at 6 hours and applying a correction 
factor derived from the loss of (125 r) labelled albumin 
injected at the beginning of the experiment . In doing 
this· the author is aware that the more accurate technique 
would be the use of a computer to embrace all the factors 
previously mentioned . 
Specific activity of urea at is derived from 
to 
the 6 hour sample on .the day of the experiment and extra-
polated to zero time by applying the slope of exogenously 
administered ( 14c) urea injected on day 2 . The author is 
aware that the area method previously described is more 
accurate, but both .the lack of facilities for measuring (13c) 
urea and the inability to obtain an accurate endogenous ( 14c) 
urea slope under conditions of protein restriction precluded 
its use. 
The technique proposed by Reeve and McKinley (1970) 
would appear to be ideal under the experimental conditions 
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app lied in this study. However, because of the radiation 
hazard it is doubtful if this method of constant ( 14c) 
bicarbonate infusion will be used in humans. 
Radiation hazard . 
Morgan (1947) and Marinelli et al, (1948) have calcu-
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14 lated that if a total dose of 100 pc of Na 2 co3 were uniformly 
distributed throughout the body of a 70 kg man, approximately ' 
4.5 microcuries per day would be delivered to the tissues. The 
maximum permissible level of 40 microcuries per day was 
suggested by the U.S. Atomic Energy Commission (Manove and 
Lintz, 1949). Three important points require expansion: the 
fraction of the total dose retained, the question of a selective 
tissue concentration of the isotope and the form in which the 
isotope is retained. 
The data of Armstrong et al (1948), Greenburg and 
Winnick (1949), Gould et al (1949) and Skipper et al (1949a,b) 
in rats and mice suggest that 95% of the administered dose of 
Na 2
14co 3 ,or NaH14co3 was lost in the expired air within 4 hours, 
and that less than 2% of the dose persisted in the animal for 
more than twenty-four hours after i .ntrc;peritoneal injection. 
In humans, Hellman et al (1951), after giving 200 pc 
of (2-14c) glycine or (2-14c) acetate orally to patients with 
incurable disease, found that in two patients who died one 
month and eight months later the body retention of the dose 
was 12 % and 1.2% respectively. The work of McFarlane (1963a) 
with totally labelled ( 14c) arginine and ( 14c) carbonate 
suggests that not more than 1% of the administered radio-
activiti would be retained in protein 24 hours later. 
Retained radioactivity is probably all in the protein fraction 
a s radioa ctivity in non-protein products is associated 
with materials of short biological half-life. 
Concent ration o{ the isotope has been examined in both 
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a nimals and man . While the work in ~ats (Kornberg et al, 1951, 
1952), mice (Skipper et al, 1951), and rats (Bloom et al, 1947) 
suggested high concentrations in bone, Berlin et al (1952) found 
t he bone concentration in a patient who died 526 days after 
receivin g 2- 14c glycine not greatly different from other tissues. 
In summary, it appears that about 2% of the administered 
dose is retained and that this is reasonably evenly distributed 
t h roughout t he body. The author has given 200 pc to subjects 
on a normal diet and then 200 pc to the same subject on a 
10 gram per day protein diet which was shown to decrease muscle 
and plasma protein synthesis (Waterlow and Stephen, 1968) 
thereby decreasing isotope incorporation. Apparently the 
British Medical Research Council is permitting 2 doses each 
of 200 µc of (14c) carbonate to normal patients on normal diets. 
Rothschild et a l (1969a) reported the use of similar doses in 
America. In view of this, the dose used appears acceptable, 
particularly under the conditions of study. 
Validation o f te c hn ique . 
This has b een app roa che d in two ways : 
(1) t he measurement of synthesis and catabolism independently 
in t h e s ame animal or man in a steady state. From the work 
o f McFar l ane (1963a), Rosender (1967), Kirsch et al (1968), 
Tavi l l et al (1968) and Jeejeebhoy et al (1969) it appears 
that reasonab le matching between the two methods has been 
ob tained. 
14 (2) the measurement of synthesis by the ( C) carbonate and 
immunological techniques simultaneously in the isolated 
perfused liver . . Both Hoffenberg et al (197l) and Katz et 
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al (1967) obtained fair approximation between ~he two methods. 
From these two approaches it appe-ars that the method 
is acceptable in principle , the assumptions reasonable and the 
technical problems mentioned not limiting for meaningful 
results. However, it is possible that small differences in 
experimental conditions could be missed and, in fact, Tavill 
et al (1968) found albumin synthesis rates to vary by as much 
as 20 % in the same patient under the same conditions. 
Liver perfusion . 
The system for the isolated perfused rat liver is 
depicted in Figure 9. The assumption is made that, for 
practical purposes, the entire system is closed. Therefore 
a modification of the original formula (Equation 4) can be 
utilised: 
Mass of albumin synthesized in time t = 
Radioactivity incorporated 
into guanidine carbon of X 
arginine in albumin int 
Mass of urea 
synthesized 
int 
Radioactivity incorporated into urea int 
= Equation 10. 
The modifications to the four components of the system are 
outlined below:-
(1) The urea system. 
A closed system is assumed due to the absence of the 
gut bacterial degradation and the renal excretion of urea. 
However, urea can theoretically be lost in the bile or by 
degradation caused by urea-splitting organisms in the blood. 
red cell 
arginine 
plasma arginine 
liver arginine --,l)~ plasma albumin 
I 
I 
I 
albumin catabolism 
---------.~--------------
urea pool 
urea degradation 
Figure 9: THE ARGININE; ALBUMIN AND UREA POOLS OF THE CARBONATE 
METHOD IN THE PERFUSION SYSTEM 
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Biliary excretion of urea can be discounted, but degradation 
of urea .by bacteria is a real possibility as the liver perfusion 
technique is a non-sterile technique and blood cultures performed 
by the author have revealed some bacterial growth, including 
urea-splitting organisms. The author has excluded significant 
urea degradation by demonstrating constant urea radioactivities 
during perfusion when exogenously labelled (14c) urea was 
adrn'inistered. The assumption of a closed urea system is 
therefore probably justifiable. 
Urea synthesis rates were obtained from the difference 
between the plasma stable urea before and after perfusion and 
assuming distribution throughout the blood volume. While the 
urea synthesis rate varied under different experimental 
conditions, it nevertheless remained constantthroughout any 
one particular perfusion. 
(2) The arginine system. 
The same assumption is made that the precursor specific 
activity o f arginine is identical at the sites of urea and 
albumin synthesis. 
Red blood cell haemolysis, which released most amino 
acids and arginase, occurred to some extent and was constant 
for all perfusions . The released arginase would have had no 
influence on the arginine system because of the absence of 
extra-hepatic protein catabolism and the use of (14c) carbonate 
. rather than the (6- 14c) arginine. 
(3) The albumin system. 
The assumptions introduced are that the albumin system 
is a closed one in that the distribution of albumin is 
limited to the plasma, and that albumin catabolism by the 
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liver is negligible. While albumin is known not to penetrate 
red blood cells, distribution within the iiver has been ignored 
by the author. A correction factor is . difficult to apply. 
The usual expedient of using the (125I) albumin correction 
factor suffers from the same problems previously mentioned, 
while the percentage change is small enough to be almost 
meaningless. Blood volumes and liver weights remained 
relatively constant in the different perfusions and the distri-
bution correction can probably be ignored. On the other han~ 
albumin catabolism by the isolated liver certainly occurs, albeit 
at a relatively slow rate of 0.1% per hour of the intravascular 
pool. For this to be ignored it is essential that albumin 
catabolism remain constant under all experimental conditions. 
The author has undertaken to show this later in this thesis. 
In spite of omitting these corrections both Hoffenberg et al 
(1971) and Katz et al (1967) obtained reasonable agreement 
between this method and the simultaneous measurement of albumin 
synthesis using an immunological technique. 
14 (4) The ( C) label.· 
The labelling of the guanidine carbon of arginine 
was achieved by an injection of (14c) carbonate into the 
reservoir. (6-14c) arginine suffers from the problems of 
red blood cell arginase previously mentioned . Administration 
of the label into the portal vein is a more direct and 
efficient method . Injection into the reservoir is techni-
. cally simpler but presents the hazards of continuous 
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labelling of the hepatic arginine pool instead of a "pulse-
like" method . However, the author has found that within 
a few minute s the (14c) carbonate is lost from the 
system, analogous to peripheral vein injection in the 
intact animal. Katz et al (1967) have also shown that 
the constant infusion of (14c) carbonate gives similar 
results to those obtained by using a single injection. 
Th e (14c) bicarbonate infusion method proposed 
by Reeve and McKinley (1970) would offer a more direct 
method and would enable the urea problems to be avoided. 
ALBUMIN CATABOLISM . 
Techniques for the measurement of albumin catabolism 
have become well established. Initial attempts employing 
labelled amino acids suffered from the disadvantages of the 
slow rate of incorporation of the labelled amino acid into 
protein and, more fundamentally, from the re-utilisation of 
the labelled amino acid resulting, from protein catabolism. 
Iodine-labelled albumin was introduced in the 1950's 
131 
as a means of measuring catabolism. When the ( I) albumin 
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molecule is degraded, the iodide attached to tyrosine is 
released. The behaviour of both the ( 131 I) iodide and the 
(131 i) albumin has been used as an index of albumin catabolism. 
The assumption that (131 I) ,i s liberated only during reactions 
involving rupture of peptide bonds was validated by the work of 
Cohen et al (1956) and Campbell et al (1956), who showed the 
half-life of protein lapelled with iodine to be almost identical 
with that of the corresponding protein labelled with (14c) by a 
biosynthetic prcedure. Cohen et al (1956) excluded reutilisation 
of (131 I) iodide on the grounds that they failed to detect plasma 
protein labelling, and achieved almost complete recovery of the 
label in the urine within two days after feeding animals (131 I) 
proteins. 
After injection of the (131 I) albumin it is rapidly 
distributed throughout the intravascular space, the extent of 
its dilution after ten minutes providing a measure of the 
plasma volume. ( 131 r) albumin may leave the intravascular 
space by catabolism, migration to the extravascular space or 
pathological losses from the kidney, gut or other sites. 
48. 
For the following three days distribution throughout the extra-
cellular space occurs. After three days the semi-log plot of 
the plasma radioactivity against time is found to be linear. 
Provided no losses occur in the urine, gut or other sites, this 
slope has been used to calculate the albumin catabolic rate 
(Sterling, 1951). However, as depicted in Figure 10, there 
is a bidirectional extra- intravascular movement of labelled 
albumin and therefore as the plasma (131 r) albumin starts to 
f 11 . t . 11 . . ( l 31 ) lb . f h a 1 wi receive some I a umin rom t e extra-
vascular space. Catabolic rates obtained by this procedure 
are therefore underestimated. The degree of error will be deter-
mined by the extravascular protein mass, the rate of protein 
catabolism and the degree of vascular permeability. 
the slope of the total body curve, after preliminary 
Similarly, 
equilibration, reflects partly catabolism and partly net transfer 
of labelled molecules into the plasma compartments. Therefore, 
for plasma data to be accurate, there must be no net transfer of 
labelled protein from the extravascular to the intravascular 
space (so-called "equilibrium time") . 
. . 
Campbell et al (1956) 
proposed that at that point in time, a tangent to the plasma 
( 131 r) albumin semi-log plot against time would pr9vide a 
measure of the albumin catabolic rate as a fraction of the 
plasma protein pool, while the Y intercept of this line would 
. 
provide 'the ratio of intra- to extra-vascular pool size. In 
practice, the extra-vascular radioactivity required shows a 
broad plateau and the maximum point of the curve is difficult 
to define. 
Labelled iodide, released by catabolism, is distributed 
throughout the body water, excreted in the urine, re-utilised 
by the thyroid gland and secreted and reabsorbed by the gut (see 
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Figure 10 ). Thyroid uptake can be blocked by administration 
.of stable iodine while gut secretion, because of virtually 
complete reabsorption of iodide, can · be ignored. Zizza et al 
(1959), Lewaller et al (1959) and McFarlane (1963b) have 
established t hat the majority of non-protein-bound radioactivity 
is free iodide . Therefore , the total iodide released fr om the 
labelled albumin, expressed as a fraction of the mean albumin-
bound .activity in the plasma, integrated over the corresponding 
24 hour interval, is used as a measure of albumin catabolism 
(Berson et al, 1953; Berson and Yalow, 1954). After an initial 
period of 24 to 48 hours, during which iodide activity accumulates 
in the body water, urine activities are assumed to equal iodide 
activities released by catabolism during the collection interval . 
This is a lengthy procedure of at least one week, and is dependent 
on normal renal function and accurate urine collections . It is 
clear that any method over a short period of time or performed 
in the presence of compromised renal function must provide a 
measure of the non-protein-bound activity released into the 
body water. This has been suggested by McFarlane (1963c) and 
exploited by Donato et al (1967) and Vitek et al (1967). 
Recently, McFarlane and Koj (1970) have reinvestigated the 
possibility of short-term measurement of catabolic rates using 
mean plasma albumin activities, iodide excreted in the urine 
and iodide accumulated in the body water over the period of 
measurement. They concluded that "until the pool from which 
protein molecules are withdrawn to be catabolised has been 
defined more clearly and more is known about the nature of the 
catabolic process itself, it is unlikely that meaningful 
measurement of the fractional catabolic rates can be made 
50. 
within 36 hours of injecting an iodine labelled protein". 
The author has used iodine-labelled albumin for measuring 
albumin catabolic rates both in man and in the isolated rat liver 
perfusion . 
A. Man 
The more accurate technique initially described by 
Berson and Yalow (1954) was used by the author. The F.C.R. of 
albumin was calculated from the urinary iodide excreted per day, 
after 48 hours, expressed as a fraction of the mean protein-bound 
activities in the plasma over the same tnterval. 
B. Liver perfusion study. 
In the isolated perfused liver the system is simplified 
(see Figure 11). The fractional catabolic rate is derived from 
the iodide released per hour, expressed as a percentage of. the 
mean total protein-bound radioactivity during that hour. 
The assumptions include : - . 
(i) Those common to the intact animal or man. For example 
(a) iodide released is dependent on peptide bond rupture, (b) iodide 
is not reutilised for further protein synthesis. 
(ii) The system is a closed one. (a) No "body pool" of iodide 
exists to allow for iodide distribution. The only potential 
component of the "body pool" is the liver which can be ignored 
for practical purposes. (b) Bile is a potential avenue for 
iodide or iodinated albumin excretion. However, albumin 
excretion in bile is known to be negligible while bile iodide 
excretion was shown by Cohen and Gordon (1958) to constitute 
less than 3% of the total non-protein radioactivity in the 
perfusing blodd. This was verified by the author prior to 
commencing this work (unpublished) and quantitatively can be 
ignored. 
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(iii) That (131 r) albumin is stable in the absence of a liver. 
Gordon (1957) demonstrated that radioactivity is not released 
from undenatured ( 131 r) albumin pumped through the perfusion 
circuit in the absence of a liver. 
(iv) That the injected preparation of ( 131 r) albumin contains 
negligible amounts of "free (131 r) iodide. Reference to 
Figure 11 illustrates that any free ~abelled iodide injected 
into the system will result in confusion of the final F.C.R. as 
these rates are extremely low in this system. Non-protein radio-
activity was shown to constitute less than 0.2% of total radio-
activity injected. 
RIBOSOMAL PROFILES. 
In 1963 it was demonstrated by electron microscopy and 
sucrose gradient analysis that ribosomes and mRNA are arranged 
in aggregates called polysomes (see Review on Amino Acid Pools). 
A ribosomal profile represents the size distribution of the 
ribosomes . The ribosomes are closely packed together and the 
size of the polysome aggregates is therefore a measure of the 
length of the messenger strand. Wettstein et al (1963) have 
shown that from the centre of one ribosome to the next on a 
polysome, the messenger extends for 19 nucleotides or 30 codons. 
Therefore a protein with 560 amino acids such as albumin will 
be coded for by a messenger carrying 19 ribosomes. The 
aggregate size-to-messenger relationship has been confirmed by 
several workers (Borun et al, 1967; Heywood et al, 1967; 
Kiho, 1968). Furthermore, following the suggestion of Birbeck 
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and Mercer (1961), the bulk of evidence favours the functional 
separation of ribosomes into free and membrane-bound components. 
Redman et al (1968), Takagi and Ogata (1968), and Hicks et al (1969) 
have confirmed that albumin is synthesized exclusively on the 
membrane-bound ribosomal population. Also, from the work of 
Gaetani et al (1969), it appears that the two populations can 
behave differently under differen~ conditions. Monosome 
accumulation is a fairly sensitive indicator of polysome 
breakdown and therefore decreased protein synthesis. · Ribosomal 
profile analysis can therefore yield valuable information 
concerning either overall protein synthesis (ratio of monosomes 
to polysomes) or specific protein synthesis (different populations 
of ribosomes or different size proteins within these ribosomes.) 
Many modifications of the original method of preparing 
C ribosomes (Wettstein et al, 1963) have been described. For 
considerations mentioned above,the procedure of Blobel and 
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Potter (1967) was used by the author. 
the method are discussed below:-
The five basic steps of 
(1) The use of RNase inhibitor. 
(2) Differential centrifugation. 
(3) Zonal centrifugation. 
(4) Release of membrane-bound ribosomes. 
(5) Profile preparation and analysis. 
(1) The use of RNase inhibitor. 
In the cell there is a delicate balance between RNA, 
RNase and RNase inhibitor. Blobel and Potter (1966) and 
Lawford et al (1966) have shown that any prolonged procedure 
results in breakdown of RNA as a consequence of RNase activity. 
Blobel and Potter (1967) recommend adding liver cell sap 
which contains RNase inhibitor to the homogenising medium to 
prevent this action. This liver cell sap is prepared from 
the post mitochondrial supernatant by centrifugation at 
105,000 g for 4 hours . The RNase inhibitor contained in the 
cell sap is stable for at least one month at -200 (Shortman,1962). 
Therefore all steps of the method are carried out in the presence 
of RNase inhibitor. 
(2) Differential centrifugation. 
This step involves the separation of the total ribosomal 
population from the cell wall, nuclei, debris and mitochondria. 
Unfortunately, a large percentage of the membrane-bound 
ribosomes sediments and is therefore not included in the post 
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mitochondrial supernatant. Blobel and Potter (1967) have 
shown that the post mitochondrial supernatant fraction contains 
more than 90% of the free ribosomes but only about 20% of the 
bound ribosomes. However, Lawford et al (1966), by preparing 
polysomal profiles from the pellet usually· discarded, showed that 
the post mitochondrial membrane-bound ribosomes are probably 
representative of the total membrane-bound ribosomes. 
(3) Zonal centrifugation. 
The separation of free from bound ribosomes is based 
on the lower molecular weight of the lipoprotein-bound fraction. 
The free ribosomes pass through 2M sucrose and form a pellet at 
the bottom of the centrifuge tube, whereas the membrane-bound 
fraction is held at the interface. 
(4) Release of membrane ,-bound ribosomes. 
The interface containing the ' lipoprotein-ribosome 
combination is recovered. The lipoprotein membrane is -removed 
by homogenisation with a detergent and the bound ribosomes 
prepared by centrifugation through sucrose. 
(5) Ribosomal profile preparation and analysis. 
The pellets are spun through linear gradients and passed 
through a flow-through cuvette in a spectrophotometer, set 
at 260 mp linked to an automatic recorder. Essentially, the 
size distribution of the ribosomes in the gradient is 
indicated by the distribution of the RNA as there is no 
evidence to suggest variation in ribosomal RNA content. 
The final profiles are probably defective in the 
following ways:-
(i) Munro (1970) considers that the technique used in centri-
fuging the free and later the bound ribosomes through 2M sucrose 
suffers from the same criticism as the original C-ribosome 
procedur~ of Wettstein et al (1963). Munro considers that some 
monosome particles with sedimentation prope~ties similar to those 
of ferritin are excluded from the final population. The author 
is aware that this may be a serious limitation to the technique 
of Blobel and Potter (1967) used, in that monosome changes may 
be the most sensitive ·index of changes in protein synthesis. 
The preferred technique of excluding ferritin without losing 
these monosomes by the· use of ferritin antiserum was not 
available to the author (Drysdale and Munro, 1967). 
(ii) The cell sap added in the preparation of the final gradient 
contains ferritin , an iron-containing protein which sediments 
over the range 20-120S and is maximal at 60-70S. The iron of 
ferritin absorbs strongly in ultraviolet light and its presence 
can therefore lead to errors in estimating monosomes and disomes 
(Jackson et al, 1964). 
(iii) The author was unable to obtain the quality of separation 
achieved by workers such as Noll (1969), although profiles 
were obtained very similar to those of Blobel and Potter ( l J 
and others using this method. 
(iv) The disome peak in liver cell preparations is preferentially 
increased under some conditions in which monosomes accumu}ate. 
This is considered to be due to physical aggregation of 
monosomes which have neither peptide chains nor messenger 
j 
attached to them. 
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In view of the limitations mentioned, it must be stressed 
that all specimens were handled in an identical fashion . 
Furthermore, no attempt was made to quantitate profile peaks . 
Instead minor differences were ignored and only gross 
qualitative differences compared . Thus ribosomes were considered 
to show either "aggregated" or "disaggregated" patterns . 
Essentially, the author has therefore examined ribosomal pro files 
considering both overall protein synthesis ("aggregated" o r 
"disaggregated") and spe c ific protein synthesis (the profi l e 
of free or membrane - b o und ribo s omes. ) 
LIVER PERFUSION. 
, 
The intact animal has a remarkable ability to maintain 
the internal environment in response to external stimuli. 
Conversely, isolated cell function is frequently too crude to 
provide useful information. Between the two lies perfusion 
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of the isolated organ. While liver perfusions we~e attempted 
in the late 19th Century and early 20th Century, it was largely 
through the efforts of Miller et al (1951) and Brauer et al (1951) 
that the isolated rat liver perfusion became established as a 
maj or tool for biochemical research . 
The perfus ion technique has varied with the investigator 
and the requirements of the experiment. Basically, the technique 
consists of cannulation of the portal vein for inflow of the 
perfusion medium, . cannulation of the bile duct and transfer 
of the liver, removed from the carcass, in situ to a temperature 
controlled cabinet. The two-component system (liver and 
perfusion medium) is kept at physiological pH, oxygen and 
carbon dioxide tension and the essential nutrients are supplied. 
The duration of perfusion has varied with the modifications 
and requirements of the investigator. Basic technical details 
include minimising manipulation of the liver during its removal, 
avoiding lengthy periods of hepatic anoxia and establishing a 
perfusion pressure comparable to that in the rat. 
Functional criteria include basic parameters ·such as 
the general appearance of the liver, blood flow and bile 
secretion. Light . and electron-microscopy have been used to 
establish viability. As in clinical medicine, however, the 
divers~ and often intricate function of a liver precludes 
simple or even satisfactory estimates of liver function. 
Comprehensive estimates sh?uld be based ideally on hepatic 
parenchymal cell, reticulo-endothelial cell and biliary cell 
function. Thus various parameters of protein, carbohydrate 
and fat metabolism, phagocytic and degradative capacity and 
biliary excretory function should be considered. 
58. 
Miller and colleagues (1951) justified the use of the 
isolated rat liver for the study of protein synthesis by showing 
that the perfused organ: (1) discriminated between the d- and 
1- isomers of lysine with a virtual failure of response to the 
unnatural isomer; (2) repeated its action quantitatively when 
, 
a second dose of (14c) labelled substrate was given, responded 
to the removal and oxidation of amino acids and synthesized 
plasma proteins; (3) removed amino acids continuously from the 
perfusing blood and (4) responded quantitatively in a similar 
fas h ion to t hat of the intact animal in the conversion of (14c) 
a mino acids to (14c) co 2 and liver 
0
(
14c) ·proteins. 
Furthermore, a simple two-compartment system offers the 
unique opportunity of varying the nutrient or hormonal status 
of the liver or blood together or independently without wide-
spread compensatory mechanisms which occur in the intact 
animal. In addition, isotopic studies, as previously mentioned, 
are simplified by the use of this relatively closed system and 
• 
the absence of a large extravascular compartment. 
Perfusions were performed by the author according to 
the method of Miller et al (1951) as modified by Fisher 
and Kerly (1964). Full details of the methodology 
are described in a later chapter and in the Appendix. 
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IODINATION. 
The biological behaviour of a protein varies in relation 
to its sensitivity to iodination, albumin being relatively 
resistant, a mean of one atom of iodine per molecule being 
acc epted as the safe level of substitution. Cationic iodine 
is substituted into the benzene ring of tyrosine, and to avoid 
a sign ificant population of protein molecules having excessive 
substitution, mean levels are utilised which are well below 
the level resulting in denaturation. The chemistry of 
iodination has been discussed in some detail by Hughes (1957) 
and Helmkamp et al (1967a,1967b)while the problems and 
techniques involved have been described by McFarlane (1958, 1964). 
Cationic iodin~ may be formed from iodide by the use of 
oxidising agents such as hydrogen peroxide or chloramine T. 
However, the alternative methods utilising hypoiodous acid 
(HOI) in aqueous solution are less harmful to plasma protein 
molecules . The iodine monochloride method (McFarlane, 1958) 
is the most successful. 
iodine monochloride . 
.c • t· ~ Ho131 I ~orma ion o~ . 
At an alkaline pH,HOI is formed from 
Addition of radio-iodine results in the 
Rapid introduction of the Ho 131 I 
solution into the purified albumin solution increases the 
efficiency of iodination. 60-70% iodination is achieved and 
t h e residual free radio-iodide is ~emoved by passage through a 
chloride ion exchanger or by dialysis against distilled water. 
Self-irradiation damage (Yalow and Berson, 1957; Cohen, 1959) 
is reduced by the addition of unlabelled carrier protein 
(Yalow and Berson, 1957) and by the use of the iodo-alburnin 
almost immediately after preparation. Sterilisation i~ 
achieved by Seitz filtration or the use of ''millipore" filter 
units avoiding the denaturation caused by heat sterilisation 
(Merchant et al, 1957). 
While no abnormal physiochemical properties may be 
detected, the iodinated albumin may still· behave in an 
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attenuated fashion. This may be tested for by (1) introduction 
of the product into a control for comparison with the experimental 
model, (2) comparison of its plasma half-life with that of bio-
synthetically labelled · (14c) albumin, (3) detecting high catabolic 
rates of albumin in the perfused rat - liver or humans, and 
(4) finding excessive urinary radio-iodide within the first 48 hours 
after injection. 
The author is satisfied that the final product used met 
tne criterion of biological integrity. In the human studies, 
an acceptably pure commercial preparation of human albumin was 
used and the subsequent procedures performed, as outlined above. 
In the perfusion catabolic studies,the rat albumin was 
extracted by the ammonium sulphate technique (McFarlane, 1963a) 
and the purity checked by cellulose acetate electrophoresis . 
After iodination as described above, albumin was biologically 
screened (McFarlane, 1956) by intra~peritoneal injection 
into rats and bleeding 48 hours later (Gordon, 1957; Cohen and 
Gordon, 1958). 
P A R T I • 
THE EFFECTS OF DIETARY PROTEIN RESTRICTION ' 
ON ALBUMIN SYNTHESIS, ALBUMIN CATABOLISM 
AND THE PLASMA AMINOGRAM. 
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Introduction. 
The McFarlane technique for the direct measurement of 
albumin synthesis has recently been applied to man (Jones et 
al, 1968; Tavill et al, 1968; Wochner et al, 1968 ; 
Jeejeebhoy et al, 1969; Rothschild et al, 1969a; Coles et 
al, 1970) . However, little attention has been directed :-
1. to protein intake in relation to synthesis, and 
2. to synthesis and catabolism in the same patient on different 
dietary intakes. 
Hoffenberg et al (1966) and James and Hay (1968) , using indirect 
methods of measurement, concluded that albumin synthesis is 
decreased in man by protein restriction . These studies are 
supported by the work of Kirs c h et al (1968) who, using the 
(14c) carbonate technique in the rat, demonstrated a rapid 
decrease in albumin synthesis following protein restriction . 
I~ protein caiorie malnutrition (PCM) in children, low 
plasma albumin and specific plasma amino acid changes are found 
(Holt et al, 1963; Saunders et al, 1967) . Few studies of the 
plasma aminogram on controlled dietary protein restriction have 
been reported . No studies relating albumin synthesis to the 
\ 
plasma aminogram have been published . 
In view of the above considerations, it was felt that 
a study of albumin synthesis, albumin catabolism and the plasma 
aminogram in the same subject before and during protein restric-
tion would be important :-
1. to determine the magnitude of change, measuring albumin 
synthesis by a dire~t technique, 
2. ~o interpret similar studies in patients with cirrhosis , 
malabsorption and uraemia where protein depletion is 
frequently present, and 
3. to determine whether any relationship exists between 
plasma amino acid levels and albumin metabolism. 
Materials and Methods . 
Patients. 
Eight adult male subjects were hospitalised in the 
· metabolic ward of Groote Schuur Hospital . Informed consent 
was given by each patient . All subjects had normal liver, 
renal, cardiac and gastro-intestinal function and no 
evidence of infection. 
Protocol. 
After a two week screening period in the hospital 
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on a 70 gram protein diet, albumin synthesis and catabolism 
were measured . The subjects were then placed on a 10 gram 
iso-caloric protein diet, supplemented with adequate minera~s 
and vitamins. The full diet was consumed by all subjects. 
After 4-6 weeks of this diet, the synthesis and catabolism 
studies were repeated. 3 days before each study, iodine 
uptake by the thyroid gland was blocked by the administra-
tion of Lugol's iodine (10 minims 3 times daily) and the 
bowel was sterilised using neomycine sulphate (1 gram 4 times 
daily) . The Lugol's iodine was maintained for 14 days and the 
neomycine sulphate for 4 days. On the first day of the 
synthesis rate study, plasma was taken from each subject after 
an overnight fast for amino acid analysis. The subjects 
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voided urine, and then 80 microcuries of (125 r) albumin was 
administered intravenously together with 200 microcuries of 
sodium ( 14c) carbonate. Blood samples were withdrawn after. 
10 minutes, 3 hours and 6 hours and then daily for 10 days. 
Each day, 24-hour urine volumes were collected. The 
following day, after another overnight fast, 5 microcuries of 
(14c) urea were administered and blood samples taken at 3, 3~, 
4, 4~, and 5 hours. On both days of synthesis rate measure-
ment, a light, non-protein snack was provided with a liberal 
fluid intake. 
Materials and Methods . 
The principles of methodology have been discussed. 
Detailed methodology can be found .in the Appendix. 
of the essential features follows. 
A summary 
Catabolic rates were derived from urinary excretion of 
radioactive iodine as a function of plasma specific activity. 
I0dinati9n of human albumin was achieved by the MCFarlane iodide 
monochloride technique to give 0.5 to 1.0 gr-am - atoms of iodine 
per molecule of albumin. 
against distilled water. 
Free iodine was removed by dialysis 
Trichloroacetic acid precipitation 
showed less than 1% free iodine. Carrier albumin was added 
to reduce radiation damage and the preparation was sterilised 
by Seitz filtration . The labelled albumin was used within 48 
hours of preparation. The radioactivity of the serum and 
urine samples was measured in a Packard Autogamma Spectrometer. 
Plasma volume was optained by isotope dilution at 10 minutes. 
Albumin was measured in duplicate by the method of Fernandez 
et al (1966) • The intra-vascular albumin pool was estimated 
by multiplying the plasma albumin pool by the degradation 
rate constant (mean of day 3 to day 14). 
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Albumin synthesis was measured by the technique 
developed by McFarlane (1963) and Reeve et al, (1963). The 
formula used (Equation 8) was that proposed by Koj and 
McFarlane (1968). The specific radioactivity of urea was 
calculated by extrapolating the slope of the (14c) urea specific 
radioactivity curve to zero time applying the modifications 
already described. The hypothetical specific radioactivity 
of albumin was obtained by extrapolation to zero time, correct-
ing the 6 hour value by a factor derived from the distribution 
and catabolism of the injected ( 125 r) albumin. The urea 
synthesis rate was obtained from the slqpe of the semilog plot 
f (14 ) "f" t" "t t" o c urea spec1 1c ac 1v1 y versus 1me. 
Urea specific activity was measured on deproteinised 
plasma samples, incubated with urease to produce (14co 2 ) which 
was then released by the addition of acid. The volume of gas 
produced was measured manometrically on a high vacuum gas train, 
collected in phenylethylamine-methanol and counted in a 
PPO-POPOP tolue~e liquid scintillator in a Beckman Automatic 
Scintillation Spectrometer. Samples were counted to an error 
of less than 3%. The specific activity of the guanidine carbon 
of arginine in albumin was obtained by extraction of albumin 
from the plasma by the acid ethanol method (Korner and Debro, 
1956) . After acid hydrolysis at 110°, the sample was passed 
through a bicarbonate resin column to separate arginine which 
was then incubated with arginase to produce urea. The sample 
was then treated as for urea. Urea was measured using an 
66. 
autoanalyser. Tryptophan was measured by the method of Hess 
a nd Udenfriend (1959), while the other amino acids were 
analysed on a Technicon amino acid analyser . 
Results . 
Table I shows the absolute albumin synthesis and 
catabolic rates on the 70 gram and 10 gram isocaloric protein 
die t . . Patient 2 was reported to be disobeying dietary instruc-
tions intermittently. Table II summarises the changes in 
absolute and fractional s ynthesis and catabolic rates, plasma 
urea, plasma albumin and the plasma volume. While the plasma 
volume was unchanged, the plasma urea and the plasma albumin were 
reduced. Both the fractional and the absolute albumin synthesis 
and catabolic rates were markedly reduced following protein 
restriction. 
gram. 
Table III shows the changes in the fasting plasma amino-
Alanine is the only amino acid to show any change and is 
markedly increased on the restricted pro tein diet . 
TABLE I. 
The absolute albumin synthesis and catabol~c rates in 
subjects on a 70G and a lOG iso-caloric protefn diet. 
70G Protein Diet 1 10G Isa-caloric Protein Diet 
Patient 
Synth~"sis -Catab~l~ Synthesis ,Catabolic 
Rate* · RateX RateX Ratex 
l 398 250 101 I 184 
I 
2 225 138 257xx: I 82 
' 
3 327 163 82 I 123 I 
4 307 168 79 I 125 I 
I 
5 161 211 88 I 133 
6 95 171 33 102 
7 256 147 83 89 
. 
8 193 132 126 53 
Mean and 
standard 245+98 173+40 85+28 111+39 
- - -
-deviation 
x Expressed in mg/Kg/day 
!o::X -Reported to be eating 70G protein diet . 
intermittently. 
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T A B L E III •. 
Fasting plasma aminograms on a 70G and a lOG iso-caloric 
protein diet. 
I 
I 
, 
Amino Acid. 70G Protein Diet. lOG I so-caloric 
+ Protein Diet.+ 
' 
Glutamic Acid 0.169 + .125 . 0.332 
-
Glycine o. 304 + .070 0.349 
-
Alanine ++ 0.461 + .096 0.719 
-
Valine 0.227 + .022 0.215 
-
Methionine 0.025 + .008 0.031 
-
Isoleucine 0.079 + .018 0.080 
-
Leucine 0 .128 + .034 0.130 
-
Tyrosine 0.051 
.t .008 0.051 
Phenylalanine 0.056 + .014 0.064 
-
Ornithine 0.082 + .016 I 0.074 -
Lysine 0.192 + 
-
.060 0.181 
Histidine 0 .106 + .01 4 Q.094 
-
Arginine 0.098 + .0 42 0.109 
-
Tryptophan 0.02 4 + .003 0.025 
-
+ Mean (micromoles/ml) and standard deviation. 
++ 0. 001 < P < 0. 01 All other amino acids showed 
no difference. 
+ .368 
-
+ .082 
-
+ .1 44 
-
+ .03 8 
-
+ .010 
-
+ .015 
-
+ .036 
-
+ .015 
-
+ .048 
-
+ .033 
-
+ .038 
-
+ .040 
-
+ .028 
-
+ .006 
-:-
' 
'· 
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Discussion. 
A . Albumin synthesis and catabolism. 
The adaptation or man to a low protein intake has 
been extensively investigated over the past decade. An overall 
picture is gradually emerging. Picou and Taylor-Roberts (1969 ) , 
measuring total protein synthesis and catabolism and nitrogen 
turnover in infants by constant intragastric infusion of (15N) 
glycine, concluded that nitrogen turnover, protein synthesis 
and protein catabolism were all significantly higher in mal-
nourished compared to recovered infants. These res·ul ts, 
together with data obtained in the rat by continuous intravenous 
infusion of (14c) lysine (Waterlow and Stephen, 1168), led 
Waterlow to conclude that"the organism adjusts to a low protein 
intake not by a reduction of overall nitrogen turnover but by 
an alteration or diversion of metabolic pathways, such that a 
smaller proportion of available nitrogen is excreted and a 
larger proportion (though not a larger absolute amount) is used 
for protein synthesis" (Waterlow, 1968). Moreover, .different 
proteins are affected to different degrees. Thus Picou . et al 
(1966) were able to show severe depletion of total and non-
collagen protein with conservation of collagen protein in 
infantile protein malnutrition. Waterlow and Stephen (1968), 
using a continuous infusion of (1-14c) lysine, showed that 
protein deprivation caused large reductions in the rate of 
muscle protein synthesis, small changes in the rate of serum 
protein synthesis and no change in liver protein synthesis. 
Albumin metabolism, particularly catabolism and 
distribution, has been fairly extensively studied. It has 
been clearly established that the body attempts to maintain the 
circulating albumin mass at a conitant level within fairly 
narrow limits. In children, Picou and Waterlow (1962) 
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and Cohen and Hansen (1962) showed a reduction in the 
catabolic rati of aibumin during protein depletion . Similar 
changes were shown by James and Hay (1968) and Hoffenberg et 
al (1966), who showed a marked fall in albumin catabolism in 
adults on a very low protein intake . Gitlin and Borges (1953), 
Humphrey and McFarlane (1954) and Gitlin (1955) claimed that 
catabolism of plasma protein is mainly a first - order process . 
This homeostatic mechanism would tend to maintain a constant 
plasma protein pool size . A change in pool size would be 
associated with a proportional change in the absolute amount 
of protein catabolised, and the pool would be restored t o its 
original size provided that protein synthesis continued at the 
same rate . However, the work of Reeve and Roberts (1959) , 
Hotfenberg et al, (1966) and others suggests that this may be 
an oversimplification, as changes in the fractional and 
absolute rates of albumin catabolism may o ccur without 
corresponding changes in serum albumin concentration o r total 
intravascular albumin mass . 
Numerous workers (Hoffenberg et al, 1966; Cohen and 
Hansen, 1962; Sellers et al, 1966) have shown that on protein 
restriction the body attempts to maintain the constancy of 
the intravascular albumin mass by the transfer of albumin 
from the extra- to the intra- vascular compartment . This 
shift is rapidly reversed on refeeding protein (James and Hay, 
1968). 
Until recently, albumin synthesis measurements were 
technically inaccurate . There are few studies of albumin 
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synthesis during protei'n depletion. Using the "synthesis 
and transfer rate" index described by Matthews (1961), Freeman 
and Gordon (1964) and Hoffenberg et al (1966) found that 
albumin synthesis was reduced in rats, rabbits and human 
subjects on a low protein diet. James and Hay (1968) studied 
the fate of injected iodinated albumin using a method of 
computer analysis in children on varying protein intakes. Their 
results suggest that the rate of synthesis is more dependent 
on the immediate dietary protein intake than on the serum 
albumin concentration or the intra-vascular albumin mass, and 
that the reduced rate of synthesis occurs earlier than the 
compensatory adjustment in catabolism. Kirsch et al (1968), 
using the direct method of McFarlane (1963), drew similar 
conclusions in rats. Recently, Coles et al (1970) measured 
albumin synthesis by the method of McFarlane in 2 patients with 
severely compromised renal function on 20 gram protein di~ts. 
The present study represents the first comprehensive attempt 
to measure albumin synthesis and catabolism independently on 
different dietary protein intakes in the same subjects free 
from complicating disease states. 
The McFarlane technique has been validated by the 
agreement obtained between synthesis and catabolic rates 
when these are estimated independently under steady state 
conditions, in which the 2 are presumed to be equal. Tavill 
et al (1968), Jeejeebhoy et al (1969), Rosenoer et.al (1967), 
McFarlane (1963a), and Kirsch et al (1968) obtained 
fairly good agreement between the albumin synthesis rate 
14 
measured by the ( C) carbonate technique and the catabolic 
rate measured with iodinated albumin in a steady state. It is 
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r e levant that after two weeks on a 70 gram protein diet, there 
is poor correlation between synthesis and catabolic rates 
measured independently in the same subject in this series. It is 
possible that at this stage the subjects were still adapting to 
a protein load greater than normal. 
A major attribute of the (14c) carbonate technique is 
the minimal recycling of the label. In the case of the labelled 
guanidine carbon of arginine, recycling is minimised by the 
presence of arginase in the liver. Since hepatic arginase is 
reduced (Schimke, 1962) on a low protein diet, it is conceivable 
that labelled arginine released by catabolism is then re-utilised 
and could thus give fallacious albumin synthesis rates. However, 
catabolism is decreased in these circumstances and moreover, any 
re-utilisation would tend only to underestimate the reduction in 
the albumin synthesis rate. 
This study therefore demonstrates a marked reduction in 
albumin synthesis and catabolic rates on protein restriction. 
The disproportionate fall in synthesis relative to catabolism 
results in a drop in the serum albumin concentration in spite of 
the compensating shift of albumin from the extra-vascular to the 
intra-vascular pool. 
It is interesting to compare the results . of this study 
with those of Hoffenberg et al (1966) who measured albumin 
catabolism and "synthesis and transfer" in subjects under the 
same conditions as reported in this study. (Table IV). The 
. 
results obtained by the different methods are similar but 
indicate that "synthesis and transfer'' tends to overestimate 
the albumin synthesis rate on protein restriction. While this 
work was being completed, Coles et al (1970) reported reduced 
a l b umin catabolism and synthesis in uraemic patients . They 
TABLE IV 
C_omparison between the results of Hof fenberg et al · (19 6 6) 
and those of present study. 
f NORMAL DIET t lOG PROTEIN DIET 
r 
. I. 
Present Hoffenberg Present I Hoffenberg 
I study et al study . et al ! 
I ! -r ·1 I 
I i I 
I 
i 
! I 
I 
Fractional synthesis ' I I rate* r 14.9 8 . 9}flfl{ I 5.9 5 _8xxx i I I I I I Fractional catabolic I I I I. I rate x I 10.9 8 . 8 6 .5 6.5 
Absolute synthesis ' 
rate xH 245 15Q'OtM 85 103 *** 
Absolute catabolic I I 
ra t e ** 173 151 111.0 103 
X % of intravascular pool/day 
mg/Kg/day 
XXX 
"synthesis and transfer" . 
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obtained albumin synthesis rates of 120 and 100 milligrams per 
kilogram per day in .2 uraemic patients on 20 gram protein diets. 
They concluded that changes in albumin metabolism in uraemia 
were probably secondary to the dietary changes rather than .to the 
renal disease itself . This study, using a direct technique for 
measuring albumin synthesis, therefore confirms the work of 
previous investigators and serves to emphasise the importance of 
measuring albumin catabolism and particularly albumin synthesis 
under controlled dietary conditions. 
It is therefore quite clear that the dietary protein 
supply directly influences albumin synthesis. Mariani et al (1963) 
and Gaetani et al (1964) have shown that there is an increase in 
the activity of amino acid activating enzyme systems in the liver 
on a low protein diet. In these circumstances, there is a 
decrease in the amino acid activating enzymes of muscle (Stephen, 
1968) and a decreased activity of urea cycle enzymes (Schimke, 1962). 
Therefore an amino acid entering the body under conditions of 
reduced protein supply will have a greater chance of being 
incorporat~d into protein and a smaller chance of being deaminated 
or incorporated into muscle protein than would occur on a normal 
protein intake. Following this initial adaptation, albumin 
synthesis would be progressively slowed, presumably due to lack 
of further substrate, defective machinery or altered controlling 
mechanisms . At what level is the protein load exerting control? 
Apart from early post-natal life, proteins are absorbed only as 
amino acids. Therefore are the amino acids acting as substrate, 
trigger mechanisms for protein synthesis or do they influence 
synthesis by their release of hormones (see review of amino acid 
pools) or by some as yet undetermined manrier? Furthermore, are 
some amino acids invested with special controlling properties 
or, at a higher degree of sophistication, are certa1n amino 
acids infl.uencing the synthesis of only certain proteins? 
72. 
The relationship between amino acid levels and augmented 
protein synthesis has been discussed in geheral in the review on 
amino acid pools. There can be little doubt that hormones 
figure predominantly in. that not only do they influence tissue 
and plasma amino acid levels and are themselves influenced by 
a mino acid levels but also their influence on protein synthesis 
' 
is well described (see review on amino acid pools.) It has been 
shown that excess thyroid hormone (Rothschild et al, 1957) and 
excess steroid hormones (Rothschild et al, 1958; Grossman et al, 
1960; Sterling, 1960) increase both the absolute and fractional 
synthesis and catabolic rates of albumin. Moreover, Kernoff (1970) 
has shown growth hormone to play a role in increasing both albumin 
synthesis and albumin catabolism in the hypophysectomised rat. 
The role of amino acids in albumin synthesis is described in the 
following section. Here hormonal influences have been excluded 
by ~sing the isolated perfused rat liver. 
One would anticipate that a consideration of the functions 
of albumin would provide insight into controlling mechanisms other 
than by amino acids. 
albumin include ·-
The functions which have been ascribed to 
1. acting as an amino acid pool in a form unable to be lost from 
tha body via the kidneys; 
2. acting .as a transport system, and 
3. matntaining the colloid osmotic pressure within the vascular 
system. 
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It is interesting to note that the 12 grams of amino 
acids released by albumin catabolism per day together with the 
catabolic products of other plasma proteins would go a long way 
toward p roviding the daily requirement of 50-60 grams of 
amino acids. However, if albumin were ·an amino a,cid sto:i;e, then 
protein deficiency would be expected to result in increased and 
not decreased metabolism. 
Albumin certainly participates in the transport of 
numerous substances by virtue of its extensive surface area 
(Bennhold, 1965) and its particul~r avi~ity for anions (Scatchard 
et al, 1944; Karush, 1950). Normally, albumin provides the 
carrier for bilirubin, porphyrins, uric acid, acetylcholine, 
fatty acids, copper, calcium and zinc. When present in excess, 
v itamin A, vitamin C, thyroxine, triiodothyronine, cortisol, 
progesterone, aldosterone, oestrone and histamine are trans-
ported by albumin . In addition, numerous drugs are transported 
such as barbiturates, digoxin, aspirin, penicillin, sulphonamides, 
dyes, P . A.S . , tolbutamide and others. However, in all cases the 
albumin molecule is a non-specific vehicle and its role can be 
replaced by other proteins. 
Albumin exerts 75 % of the total colloid osmotic pressure 
within the intra-vascular compartment by virtue of its high 
concentration and relatively small size. However, once again 
this function appears to be non-specific. 
In spite of the above proposed functions, patients with 
analbuminaemia appear to be little inconvenienced by their 
lack of albumin. Feedback control mechanisms examined from a 
functional point of view have been limited. Nonetheless , a 
' 
colloid osmotic regulatory system exerting control over 
albumin synthesis has been proposed (Bjorneboe, 1946; Rothschild 
et al, 19 6 2) . Rothschild et al (1965) considered that their 
data was consistent with the hypothesis that albumin synthesis 
was regulated by the albumin concentration within the hepatic 
interstitial space. However, albumin infusions in man (Tavill 
et al, 1968) and in the rabbit (Rothschild ' et al, 1968) were 
unable to retard albumin synthesis consistently. However, 
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dextran and hypergammaglobulinaemia were able to depress albumin 
synthesis in rabbits (Rothschild et al, 1961, 1962, 1968 ,) . 
Moreover, dextranand excess albumin were shown to inhibit albumin 
synthesis in the isolated perfused rabbit liver system (Rothschild 
et al, 1967, 1969b). Oratz et al (1970), from subcelluJar work, 
considered that dextran both decreases the fraction of membrane-
bound ribosomes and prevents the ribosome from binding to mRNA . 
It· is uncertain whether this is related to changes in colloid 
osmotic pr'essure induced by dextran or to other changes such as 
amino acid or tissue hormone levels . 
From this discussion it would appear that only amino acid 
supply, hormones and the colloid osmotic pressure have been shown 
to influence albumin synthesis. 
B. Plasma aminogram . 
In a review of the plasma aminograms of children receiving 
low protein intakes in many countries, Holt et al (1963) concluded: 
1. that there is a decrease in the concentration of the plasma 
essential amino acids, particularly of the branched chain amino 
a cids, and least of phenylalanine and lysine, and 
2. that the nonessential amino acids tyrosine, arginine, 
citrulline and alpha-amino N-butyric acid decrease. The other 
non-essential amino acids glycine, alanine, serine, proline, 
histidine and aspartic acid are either unchanged or even rise 
above normal values. 
Studies in normal adults on low protein or protein:free 
diets have shown varying patterns. Tuttle et al (1957) and 
Swendseid et al (1968) showed a reduction in valine and alpha-
amino N-butyric acid on a low protein diet, but a rise in 
methionine, glutamine, asparagine, glycine and alanine. 
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However, Adibi (1968) found a marked elevation of plasma alanine 
concentration and, to a lesser extent, an elevation of the glycine 
concentration in normal subJects after 2 weeks on an iso-caloric 
protein- free diet. This is similar to the findings reported in 
this thesis of a raised plasma alanine after 4 to 6 weeks on a 
10 gram iso-caloric protein diet. When one considers that 
al~nine, together with glycine, glutamic acid and aspartic acid 
constitute 80% of the free amino acids in the body, it is hardly 
surprising that any changes would be detected first in this group. 
In fact, Felig et al (1969) consider that alanine serv~s as a 
vehicle of transport for nitrogen arising from amino acid 
catabolism in the periphery. The differences between the 
studies reported above are probably due to the variations in 
individuals, protein intake, caloric intake, meal spacing and 
duration of the studies. Interpretation of animal studies 
is even more difficult as protein restriction is accompanied 
by anorexia and decreased caloric intake. Pair-fed controls 
are unsatisfactory as these animals consume the reduced intake 
so rapidly that they are virtually fasting by the time of the 
experiment. Forced feeding is limited by the metabolic changes 
wh ich occur (Sidransky and Farber, 1958; Sidransky and 
Verney , 19 64) . Since plasma amino acid concentrations may 
have no bearing on hepatic intracellular amino acid levels, 
the relationship of the low synthesis rates to the elevated 
p lasma alanine levels may even be fortuitous or the result 
of 2 processes acting at different sites. 
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PART II. 
THE EFFECTS OF AMINO ACIDS ON ALBUMIN SYNTHESIS IN 
THE ISOLATED PERFUSED RAT LIVER. 
77. 
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Introduction. 
While recent workers have confirmed that protein restric-
tion reduces albumin synthesis both in man (Coles, 1970; present 
thesis, Part I) and in the rat (Kirsch et al, 1968), the 
mechanism involved remains to be established. The changes in 
the plasma aminogram in PCM (Holt et al, 1963; Saunders et al, 
1967) suggested that certain amino acids may influence protein 
synthesis selectively. Indeed, Pronczuk et al (1968) have 
shown that tryptophan deficiency results in diminished incor-
poration of amino acids into rat liver protein, with associated 
ribosomal disaggregation. Similar results have been obtained 
in mice (Sidransky et al, 1968). While tryptophan appears to 
have this specific function in vivo, the work of Hanking and 
Roberts (1964, 1965) suggests that individual amino acids can 
stimulate protein synthesis and increase ribosomal activity in 
vitro, irrespective of the size of the amino acid pool. In 
contrast, Baliga et al (1968) have shown that the aosence of 
any amino acid (with the exception of isoleucine) results in 
ribosomal disaggregation. 
The author has studied the influence of amino acids on 
albumin synthesis in the isolated perfused rat liver. This 
technique permitted the study of individual amino acids · using 
both fed and fasted liver donors without changes in hormonal 
levels. 
While this work was in progress, Rothschild et al (19690) 
reported that tryptophan . and, to a lesser extent, isoleucine 
were able to stimulate albumin synthesis in a fasted rabbit 
liver. Important differences between the present study and 
t hat of Rothschild et al (1969c) suggest that more than o ne 
mechanism is operative. 
Materi a ls and Methods . 
. • 
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The principles of the methods hav·e been discussed. The 
detailed methodology is given in the Appendix. 
features are surrunarised. 
Essential 
Perfusion apparatus and technique. 
Liver donors were 320-350 g male Wistar rats housed under 
controlled conditions of temperature, humidity and lighting. 
Two groups of donors were used·-
1. rats fed a 20% diet ad lib, and 
2. rats fasted for 24 hours. 
Both groups had free access to water. 
The perfusate consisted of 60 ml blood, 2 ml 4.2% sodium 
bicarbonate, 40 mg of heparin (heparin injection B.P. Boots Drug 
Co. Ltd., Nbttingham, England) and 25 ml plasmalyte B (Baxter-
Saphar Laboratories Limited, Johannesburg, South Africa) 
containing, in mEq/L, sodium 130, chloride -109, potassium 4, 
magnesium 3, sodium bicarbonate 28. 
volume of the perfusate was 24-28%. 
The final packed cell 
Blood was obtained by 
cardiac puncture under diethyl ether anaesthesia from 2 groups 
of rats: (1) rats fed ad lib, and (2) rats on a zero protein 
diet for 48 hours. This feed consisted of maize starch with 
mineral ·and vitamin supplements (2.2% vitamin diet fortifica-
tion mixture, National Biochemical Company, Ohio). 
Perfusions were performed according to the method of 
Miller et al (1951) as modified by Fisher and · Kerly (1964). 
Under diethyl ether anaesthesia,the bile duct and portal vein 
were cannulated, the liver flushed with plasmalyte Band then 
transferred to the perfusion cabinet. Outflow from the 
hepati c veins drained directly into a reservoir. A 95% 
oxygen aI').d 5 % co 2 mixture was passed into a glass ·"thin film" 
oxygenator at a flow rate of 750 ml/minute. The cabinet was 
humidified, the temperature controlled at 38°c ·and the portal 
pressure at 18 cm of water. 
250 microcuries of sodium ( 1 4c) carbonate were added to 
80 .. 
the reservoir after 30 minutes of perfusion. The perfusion was 
continued for a further 120 minutes to allow for complete release 
of labelled albumin into the perfusate. pH, P0 2 and PC0 2 were 
maintained at 7.35 - 7.42, 150-175 millimetres of mercury and 
35-40 millimetres of mercury respectively. Perfusate urea and 
glucose were measured on a technicon autoanalyser with appropriate 
standards . 
Albumin synthesis rate. 
This was measured by the technique of McFarlane and of 
Reeve et al as previously described. 
in Equation 10 . 
The formula used is given 
Plasma albumin was measured by the method of Fernandez et 
al · ( 19 66) . Only L isomers of amino acids (British Drug House, 
Poole, England) were added to the perfusate, each to concentra-
tions of 10 micromoles/ml, except in some experiments in which 
tryptophan and the branched chain amino acids were addec to a 
concentration of 0.05 micromoles/ml . Arginine, asparagine, 
isoleucine, lysine, methionine, phenylalanine, proline , 
threonine, tryp toph an and valine were added together to a 
concentration of 10 times their normal peripheral blood levels. 
Glucagon (U.S .P. Eli Lilly and Co., Indianapoiis, U .S.A .) when 
used, was added initially in doses of 1 mg followed by 0 . 5 
mg/hour. Amino acids were measured on a technicon amino acid 
autoanal ys er. 
Results . 
The amino acid concentrations of the perfusates used 
are shown in Table V. 48 hours of protein restriction reduced 
the concentrations of isoleucine, leucine, valine, tyrosine, 
phenylalanine, histidine, ornithine, methionine and glycine. 
Lysine was the only essential amino acid remaining unchanged. 
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Table VI shows the changes in albumin and urea synthesis 
rates expressed in mg/hour/300 g rat using well - nourished liver 
donors. When perfusate I was used, a synthesis rate of 1 .75 + 
0.18 was obtained. The use of perfusate II dropped the synthesis 
rate to 1 .11 + 0.31 (0.01< P< 0.02). Perfusate II with each 
amino acid added singly to a concentration of 10 micromoles/ml 
significantly increased albumin synthesis rates (tryptophan 
0.01< P<0.02; isoleucine 0.001 <P <0.01; lysine 0.001< P<0.01; 
gly·cine O. 02 < P < 0 . 05; alpha-amino isobutyric acid O. 02 <. P ~ O. 05 
and lysine, methionine and threonine together 0.02 < P < 0.05). 
Neither the branched chain amino acids nor tryptophan, added to 
a concentration of 0.05 micromoles/ml to perfusate II, had any 
effect on albumin synthesis (0.3(P<0 . 4 and 0.05 (P<0 .10 
Amino Acid . 
T A B L E V 
Initial amino acid concentrations of 
the perfusates. 
Perfusate I.+ 
µ moles/ml ++-1 
Perfusate II++ 
+++ p moles/ml 
Significance. 
. ++++ 
Isoleucine 0 . 0 5 6 + 0 . 00 5 ( 7 ) 0 . 0 3 8 + 0 . 00 9 ( 5 ) . 001 < P <. 01 
Leucine 0 . 10 7 + 0 . 01 2 ( 7 ) 0 . 0 6 2 + 0 . 0 2 1 ( 5 ) . 001 < P ( . 01 
Valine 0.110 + 0.011 · (7) 0.051 + 0.020 (5) 
Histidine 0.047 + 0.014 (6) 0.028 + 0.008 (5) 
Phenylalanine 0.045 + 0.005 (7) 0.030 + 0.011 (5) 
Tyrosine 0.058 + 0.005 (7) 0.028 + 0.008 (5) 
Lysine · 0.160 + 0.023 (7) 0.140 + 0.011 (5) 
!Alanine 
!Citrulline 
0.407 + 0.109 (6) 0.518 + 0.039 (5) 
0.049 + 0.013 (3) 0.040 + 0.017 (2) 
P < .ooi 
.02(P(.05 
.Ol<P <.02 
P < .001 
N.S. 
N.S . 
N.S. 
Ornithine 0 . 1 2 3 + 0 . 0 2 7 ( 7 ) 0 . 0 7 4 + 0 . 0 2 0 ( 5 ) . 001 ( P < . 01 
Taurine 
Methionine 
Glycine 
Tryptophan 
I £ Pc:r -u:J.'..l.to l : 
0.120 + 0.005 (5) 0.120 + 0.007 (3) 
0.032 + 0.005 (7) 0.020 + 0.001 (5) 
0.286 + 0.049 (6) 0.133 + 0.042 (4) 
0.018 + 0.004 (8) 0.014 + 0.003 (8) 
N.S. 
P ( .001 
P < .001 
.02<P<.05 
couu:L:_;tcd ol GO rn'.L blood from r...tlu 011 c.t 
normal diet, 25 ml Plasmalyte B , 4 ml heparin 
·(40 mg), 2 ml. 4.2% sodium bicarbonate. 
++Perfusate II: as above with the 60 ml. blood taken from 
rats on a protein- free diet for 48 hours . 
+++ Each result represents the mean and Standard Deviation with 
the number of observations in parentheses . 
++++p Value indicating significance of change between Perfusate I 
and Perfusate II . N.S. = Not sign·ificant. 
·TAB L E VI 
Albumin and urea synthesis rates (mg/hr/300G rat) in 
isolated rat liver perfusio ns using well nourished 
rats as l iver dono rs .. 
rerfusate . Albumin Urea 
Synthesis Rate Synthesis Rate 
++++ ++++ 
Perfus a t e I l. 75 + 0 . 18 (8 ) 5.81 + l. 93 ( 8) 
- -
Perfusate I I 1. 11 + 0. 31 ( 7) 6-.03 + 1.28 ( 7 ) 
- -
Perfusate II + Tryptophan+ 1.50 + 0. 2 3 ( 8) . 6 . 93 + 1.1 6 ( 8) 
-
Perfusate II + Isoleucine+ 1 . 8 2 + 0.3 4 ( 5 ) 6 .1 8 + O. 98 ( 5 ) 
- -
' I Perfusate II +(Lysine + 
(Methionine+ I (Threonine + l. 58 + O. 36 ( 5) 15.58 + 2 . 69 (5) 
-
I 
- i 
I Perfusate II + Lysine+ 2.04 0. 61 ( 5) 12.90 l. 32 ( 5) I + + I 
- I - I . 
I i Perfusate II + Glycine+ 1. 4 5 + 0. 24 ( 5) 11 .02 + 2 . 10 ( 5) I I 
-
- I I Per usate II + Alpha- I I I I amino ' I I ! isobutyric . I I I acid+ l. 47 + 0 . 16 ( 5) I 6 . 02 + 0. 81 ( 5) I 
- I -
Perfusate II + Tryptophan++ l. 45 + 0 . 34 ( 8) I 6 . 59 + 0. 55 ( 8) I 
-
Perfusate II + Branched 
chain amino 
acids++ l. 23 + 0 . 12 ( 5) 5 . 92 + 0. 66 (5) 
-
-
Perfusate I + 11 amino 
acids+++ • 2 . 3 8 + 0 . 43 ( 5) 1 4 .30 + l. 37 (5 ) 
-
-
+ Amino acid added to concentration of 10 p moles / ml . a 
++ Amino acid added to a concentratio n of 0. 05 pmo les / ml . 
+++ Amino acids arginine, asparagine, isoleucine, leuc ine, 
lysine, methionine., phenylalanine, proline, threo n i ne, 
tryptophan and valine added together to a conc entratio n 
of 10 X their normal pe r ipheral bloo d levels . 
++++ Each result represents the mean and Standard Deviation with 
the number of observations in parentheses . 
. 
-
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respectively). Arginine, asparagine, isoleucine, leucine, 
lysine, methionine, phenylalanine1 proline, threonine, 
tryptophan and valine added together to perfusate II, each 
to 10 times their normal peripheral blood concentrations, 
enhanced synthesis rates to a value of 2 .. 38 (0.02<P<0.05). 
Urea synthesis rates were the same whether perfusate I alone 
or perfusate II alone was used. The addition of lysine, 
glycine, the 11 amino acids given together (see before) or a 
combination of methionine, lysine and threonine significantly 
increased urea synthesis. However, the addition of tryptophan, 
isoleucine and alpha-amino isobutyric acid had no effect on 
urea production despite an increase in albumin synthesis rates. 
Table VII shows the changes in albumin and urea synthesis 
rates expressed in mg/hour/300 g rat using liver donors from 
rates fasted for 24 hours. Perfusion of the fasted liver 
resulted in a fall in the albumin synthesis rates without 
affecting urea synthesis rates. The combination of the 11 amino 
acids mentioned above increased albumin synthesis rates markedly. 
Irrespective of the other amino acids added or the perfusate used, 
there was no change in the albumin synthesis rates. 
with tryptophan failed to influence albumin synthesis. 
Glucagon 
However, lysine, alone or in combination, glucagon with trypto-
. 
phan and the 11 amino acids increased the urea synthesis rates. 
Glucose production was dependent on the nutritional state 
of the liver and was uninfluenced by the addition of amino 
a~ids or a change in the perfusate. Glucose production increased 
from 60 mg% in both groups to 110 mg% and 215 mg% using liver 
donors of fasted or fed rats respectively. 
In all perfusions the liver was uniformly perfused. Bile 
production was 0.5-1.0 ml/hr and the perfusion rate varied from 
1.5- 2.0 ml/g liver/min. 
T A BLE VII 
Albillllin and ·urea synthesis rates (mg/hr/300G rat) in 
isolated rat liver perfusions using 24 hour fasted 
rats as liver donors. 
I 
Perfusate. 
r erfusate I 
~ ~rfusate II 
Ferfusate 
r erfusate 
! 
IPerfusate 
t 1Perfusate 
I 
; 
; 
j 
t erfusate 
jPerfusate 
I 
II+ Try:ptophan+ 
II+ Isoleucine+ 
II+ Lysine+ 
II +(Tryptophan+ 
(Lysine+ 
I+ Tryptophan+ 
I+ 11 Amino 
Acids++ 
~ erfusate I +(Glucagon+++ 
; ( Tryptophan 
l 
Albillllin 
Synthesis Rate 
++++ 
0.50 + 0.24 (5) 
0.65 + 0.43 (5) 
0.46 + 0.14 (5) 
0.59 + 0.08 (3) 
0.48 + 0.26 (5) 
o. 70 + 0.22 (5) 
0.61 + 0.10 (3) 
1 .65 + 0.33 (4) 
0.59 + 0.03 (3) 
Urea 
Synthesis Rate 
V ++++ 
6.28 + 1.28 (5) 
6.34 + 0.97 (5) 
7.36 + 1.83 (5) 
6.63 + 0.50 (3) 
14.44 + 1.31 (5) 
14.14 + 2.09 (5) 
7.17 + 1.42 (3) 
15 . 90 + 1 . 71 ( 4) 
10.53 + 2. 70 (3) 
+ Amino acid added to a concentration of 10 pmoles/ml. 
++ Amino acids arginine, asparagine, isoleucine, leucine, 
lysine, methionine, phenylalanine, proline, threonine, tryptophan 
and valine added together to a concentration of 10 x their normal 
peripheral blood+ levels. 
+++ Tryptophan added to a concentration of 10 pmoles/ml . 1 mg 
glucagon added initially, followed by 0.5 mg/hr. 
++++ Each result represents the mean and Standard. Deviation with 
the number of observations in parentheses . 
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Discussion . 
A striking feature ?f albumin synthesis r'ate measurements 
in isolated rat liver perfusions has been the marked variation 
and the reduced rates compared with the in vivo v~lues obtained 
by different investigators (see Table VIII). 
Both Katz et al (1967) and Hoffenberg et al (1971) have 
demonstrated a fair correlation between the immunochemical and 
(14c) carbonate techniques. The remarkably raised rate obtained 
by Katz et al (1967) is unexplained. However, the bulk of 
evidenc e would suggest a rate of about 40-60% of in vivo values, 
irrespective of techniques used, in spite of the fact that the , 
liver is the only site of albumin synthesis (Miller and Bale, 
1 9 5 4 ; Kuk r a 1 et a 1 , 1 9 61 ) . 
The mean value for albumin synthesis rates in the normal 
rat in vivo, as measured by the author using the (14c) carbonate 
technique, was 9 mg/hour/300 g body weight (unpublished) . In 
contrast, when perfusate II was used the value was 1.11 mg/hour/ 
300 g. However, perfusate I, with its minimally increased levels 
of isoleucine, leucine, valine, histidine, phenylalanine, tyrosine, 
orni thine, methionine, glycine and tryptophan, was able to incre.ase 
synthesis rates to 1.75 mg/hour/300 g rat. Clearly, the varying 
synthesis rates obtained by different workers could reflect many 
factors including the perfusate amino acid concentration, 
dilution of blood and the nutritional and hormonal state of blood 
or of liver donors. 
Reference has already been made to the augmented protein 
synthesis achieved with increased amino acid supply (see review 
on amino acid pools . ) The increased amino acid supply provided 
by perfusate I led to increased albumin synthesis rates and 
A. 
B. 
TABLE VIII. 
Albumin synthesis rates obtained by different 
workers using the isolated perfused rat liver. 
I MMUNOLOGICAL TECHNIQUES 
Marsh and Drabkin (19 60) 6 mg/hr/300 g body 
Gordon and Humphrey (1960) 9-12 mg/hr/300 g body 
John and Miller (1966) 6 mg/hr/300 g body 
Hoffenberg et al (1971) 4 mg/hr/300 g body 
(1 4C) CARBONATE TECHNIQUE 
wt. 
wt. 
wt. 
wt. 
Gordon and Mutschler (1964) 60% of in vivo values. 
Katz et al (1967) 30 mg/hr/300 g body wt. 
Kirsch et al (1969) 1. 64 mg/hr/300 g body wt. 
Rosenoer et al (1970) 2.7 mg/hr/300 g body wt. 
Hoffenberg et al (1971) 5 mg/hr/300 g body wt. 
would tend to support this. However, other changes in the 
blood, such as altered hormonal levels, could have occurred 
leading to this change. Nonetheless, John and Miller (1969), 
in an extensive study, demonstrated the major role of amino 
acids in accelerating albumin synthesis and the modifying 
influence of insulin, cortisone and growth hormone. 
84. 
Levitan and Webb (1969) and Jefferson and Korner (1969) 
have shown progressive ribosomal disaggregation during perfusion. 
Jefferson and Korner (1969) demonstrated that the 11 amino acids 
arginine, asparagine, isoleucine, lysine, methionine, phenyl-
alanine, proline, threonine, tryptophan and valine added together 
to a concentration of 10 times their normal peripheral blood 
levels were able to prevent ribosomal disaggregation . The 
author has confirmed and extended these observations to the 
endoplasmic reticulum-bound ribosomes (see later chapter) . 
Under t hese conditions, albumin synthesis rates increased to 
2.38 milligrarns/hour/300 g body weight . 
The question has arisen whether protein synthesis is 
limited by specific amino acid deficiencies . . Reference has 
already been made to the correlation of a low serum albumin and 
specific blood amino acid changes in PCM. Moreover, Elwyn et 
al (1968), in their study of the quantitative role of the gut 
and the liver in amino acid metabolism found that net hepatic 
protein synthesis was associated with the uptake of the branched 
chain amino acids. The output of other amino acids was 
unrelated to hepatic protein synthesis. In the present study, 
the author, using diluted blood, was unable to confirm the 
findings of Ki rsch et al (1969), using whole blood, that the 
branched chain amino acids in physiological amounts were able 
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to increase albumin synthesis. 
The study of the role of specific amino acids in protein 
synthesis has been focussed to a large extent on ribosomal 
profiles . Jefferson and Korner (1969) demonstrated that 
omission of any one of the above 11 amino acids will result in 
diminished protein synthesis. Baliga et al (1968) could obtain 
ribosomal aggregation in vitro only if all 20 amino acids 
(except isoleucine) were present. Eliassen et al (1967) have 
shown that Chang liver cells in tissue culture undergo ribosomal 
disaggregation when arginine or glutamine is removed from the 
medium. In vivo, in the rat (Pronczuk, 1968) and in the mouse 
(Sidransky et al, 1968), tryptophan occupies this unique role . 
It appeared that the limiting amino acid was determined by the 
ease with which its pool could be depleted to a critical level . 
This concept is supported by the low intracellular levels of 
tryptophan in the liver of the rabbit (Rothschild et al, 1969c) 
and the finding of Pronczuk et al (1969) that, on feeding an 
imbalanced amino acid mixture under conditions when amino acid 
recycling is minimal, other am~no acids influence the ribosomal 
profile . While the present study was in progress, Rothschild 
et al (1969c) reported that tryptophan and, to a lesser extent, 
isoleucine increased albumin synthesis .when added to the blood 
perfusing an isolated liver taken from a fasted rabbit . This 
would suggest that, normally, the liver is dependent for short 
term supply on protein catabolism for the bulk .of amino acids, 
with the diet regulating synthesis by providing tryptophan . 
\ 
Fasting is known to result in elevated glucagon levels 
(Aguilar-Parada et al,i969) and the latter has been shown to 
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accelerate liver protein catabolism (Miller, 1960). Moreover, 
Gan and Jeffay (1967) have demonstrated the accelerated re-
cycling of liver amino acids on fasting. If a supply of trypto-
phan is not available, the increased supply of amino acid is 
wasteful and it appears that this spuridus adaptation then 
gradually declines. 
The author, like Rothschild et al (1969c) obtained a 
marked slowing of albumi~ synthesis using the fasted liver. 
However , unlike Rothschild et al, single amino acids, including · 
tryptophan and isoleucine in excess, were ineffective in 
stimulating albumin synthesis. An attempt to increase protein 
catabolism by glucagon infusion and then adding tryptophan 
failed to increase albumin synthesis. The fasted liver, 
however, responded to the addition o f the previously mentioned 
11 amino acids added to 10 times their peripheral blood concen-
trations. Probably the fasted rat liver, with its faster 
turnover than the rabbit liver, is too protein depleted by the 
I 
time of perfusion to provide the other amino acids required. 
The remarkable and unexpected finding by the author was 
the increased albumin synthesis resulting from the addition o f 
single amino acids to the blood obtained from protein depleted 
rats, perfusing livers derived from fasted rats . This would 
tend to support the finding of Hanking and Roberts (1964, 1965) 
that single amino acids are capable of stimulating protein 
synthesis in vitro. Furthermore, the finding of Rothschild et 
al (19 .69c) that both isoleucine and tryptophan individually 
increased albumin synthesis, suggests that a mechanism other 
than that dependent on critical amino acid pool depletion is 
operative. It is o f interest that alpha-amino isobutyric acid, 
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a non-metabolisable ~odel amino acid also has this property, 
suggesting that the mechanism is not one involving energy 
expenditure nor direct participation in amino acid metabolism . 
In addition, lysine is also effective, supporting the conce·p t 
that transamination is not involved. 
However, caution is required in interpreting this data. 
Roths child . et al (1969c) were unable to influence albumin 
synthesis by the addition of tryptophan to blood perfusing 
livers derived from fed rats. No experiments were condu?ted 
by the author adding single amino acids to the perfusion 
system with both liver and blood derived from well-nourished 
animals. It is possible that it is only in the setting of 
al~ered hormonal levels or other factors in the blood derived 
from 48 hours protein-depleted animals that single amino acids 
in excess influence albumin synthesis. 
PART III 
THE EFFECTS OF AMINO ACIDS AND HORMONES ON THE 
FRACTIONAL CATABOLIC RATE OF ALBUMIN. 
88 . 
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Introduction. 
While albumin degradation has been fairly extensively 
studied during the past decade, little is known of the site(s) 
or factors operative in this process. 
Campbell et al (1956) and McFarlane (1957) showed that, 
subsequent to the injection of iodoalbumin, iodide excreted 
daily in the urine represents a constant fraction of the mean 
protein-bound activity circulating in the plasma at the same 
time, and not of the total retained rad~oactivity. This 
data implied that albumin catabolism occurs in cells in close 
proximity to the intra-vascular pool. Recently, McFarlane 
and Koj (1970) favoured the view "that catabolism occurs in a 
pool of significant protein content which is either a subunit 
of the extra-vascular pool or is independent and sandwiched 
between the plasma and extra-vascular pools". 
At an organ level, the kidney has been estimated to 
degrade about 10-15% (Katz et al, 1960), the gut less than 
20% (Waldmann, 1966) and the liver 10-15% (Cohen and Gordon, 
1958; Gordon, 1962Y of the albumin catabolised by the whole 
' 
animal. 
While the absolute degradation of albumin varies generally 
with the pool size, the fractional rate remains relatively 
constant (first order kinetics). Therefore, any change in 
pool size due to abnormal losses or altered synthesis will 
result in changes in absolute albumin degradation. However, 
in certain circumstances, such as protein deprivation, the 
fractional degradation rates have been shown to alter 
(Hoffenberg et al, 1966; Kirsch et al, 1968; · Part I of this 
thesis). The mediator of this important change in the 
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fractional rate is largely unknown. The author has 
investigated this aspect with emphasis on:-
(1) the role of amino acids in the fractional catabolic rate 
of albumin (FCRA) . This has 2 objectives : (a) to validate 
the assumption, made earlier in this thesis during_measure~ 
ment of albumin synthesis in the isolated perfused rat liver, 
that amino acids do not influence albumin catabolism, and 
(b) to verify that albumin degradation is unrelated to amino 
acid supply but dependent on the albumin pool size (Kirsch 
et al, 1968). 
(2) the 0 measurement of albtunin degradation under conditions 
of maximum protein synthesis, and therefore presumably under 
conditions of accelerated proteolytic enzyme activity, and 
(3) the influence of growth hormone, hydrocortisone, ' insulin, 
glucagon and triiodothyronine on the FCRA. 
Materials and Methods . 
The principles of liver perfusion, extraction, 
iodination and screening of albumin and the measurement 
of catabolic rates in the isolated perfused system have been 
described while the detailed methodology appears in the 
Appendix . 
Both liver and blood donors were obtained from well-
nourished Wistar rats of 320-350 g, housed under controlled 
conditions of humidity and lighting and with free access to 
food and water. The iodinated albumin was used shortly 
after preparation . After perfusion for 30 minutes, the 
labelled albumin was added and blood sampled~ hourly for 
a further 3 hours. The fractional catabolic rate was 
9u . 
derived from the iod ide released per 30 minutes, expressed 
as a percentage of the mean total protein-bound radioactivity durin 
that time. Amino acids, when added, were arginine, asparagine, 
isoleucine, leucine, lysine, methionine, phenylalanine,'p~oline, 
threonine,· tryptophan and valine added together to a concentra-
tion of 10 times their peripheral blood levels. Hormones, when 
. . 
added, we!e given at . the beginning of the perfusion and there-
. 
after infused continuously. Initially, 2 units of soluble 
insulin B.P . (Boots Pure Drug Co. Ltd., - ~ottingham, England), 
2 mg of hydrocortisone (Glaxo- Allenbury's, SA(Vty) Ltd), 2 mg 
of bovine growth hormone (N.I.H.), ~ mg of glucagon(U .S.P. 
Eli Lilly & Co., Indianapolis, USA) and 20 mg of triiodothyronine 
(Glaxo Lab. Ltd., Greenford, Middlesex, England) were added in 
individual perfusions . Following the initial addition, the 
respective hormones were infused continuously at the rate of 
~ the initial dose per hour. 
Results . 
Table IX shows the results of the 28 liver perfusions. 
Hydrocortisone, growth hormone, amino acids, triiodothyronine 
and glucagon failed to influence the FCRA . However, insulin 
appeared to slow the fractional catabolic rate marginally . 
The albumin concentration . in all perfusions varied 
f rom 1.0 g/100 ml to 1.3 g/100 ml . 
Discussion 
Catabolism of albumin is thought to occur throughout 
the body. Nonetheless, the liver provides a useful, although 
limited, model for studying the control of albumin degradation. 
( l) 
( 2) 
( 3) 
. 
( 4) 
( 5) 
( 6) 
( 7) 
+ 
TABLE IX. 
The fractional catabolic rate of albumin in 
isolated rat liver perfusions using well 
nourished rats as liver and blood donors. 
Perfusate Fractional catabolic 
rate of albumin+ 
Perfusate alone I 0.075 + 0.023 ( 7) I -
I 
Added hydrocortisone I 0.069 0.031 ( 5) + 
-
Added growth hormone 0.085 
0.058 ( 2) 
Added insulin++ 0.044 + 0.017 ( 5) 
-. 
I 
Added amino acids 0.069 + 0.020 ( 3) 
-
Added triiodothyronine 0.078 
0.060 ( 2) 
Added glucagon 0.051 + 0.004 ( 4) 
-
Mean, Standard deviation and ·number of observations· 
in parentheses. 
++ Significance (1) versus (4) 0.02 < P< 0.05 
(1) versus (7) 0.05<P<O.l 
( l) versus ( 2) , ( 3) , ( 5) and ( 6) P) 0.1 
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Catabolic studies in the isolated rat liver perfusion 
have emanated chiefly from investigators from Mill Hill . Thus 
Gordon (1957), Cohen and Gordon (1958) and Gordon (1962) showed 
that the perfused rat liver catabolises about 10-15% of the 
homologous albumin broken down in the whole animal . Freeman 
et al (1958) demonstrated that the catabolism of ( 14c) heat-
denatured chicken serum proteins was decreased while that of 
native serum (131 I)· albumin was increased fivefold in perfusions 
using livers from carbon- loaded rats. More recently, Hoffenberg 
et al (1970) have published interesting data relating the FCRA 
to the intra-vascular albumin pool. They found that when 
livers from protein depleted rats were perfused with normal 
blood the FCR..n. was slightly reduced. When these livers were 
perfused with blood derived from protein deprived rats, 
minimal catabolism could be detected. Catabolism was restored 
by the addition of unlabelled albumin. These results suggest 
that both the nutritional state of the liver and parti cularly 
the intra-vascular pool of albumin regulate the FCRA . It 
should be noted, however, that the albumin concentratio~ at 
which the FCRA was markedly reduced in their work was still 
higher than the albumin concentration reported in the present 
study, at which normal FCRA · values were obtained. The normal 
FCRA results obtained by the author are similar to those 
obtained by Gordon (1962) and Hoffenberg (1970) . Only 
screened albumin was used, and it is unlikely that the present 
results are high due to denatured material . Is it the albumin 
itself, is the operative factor something in the blood from 
protein deprived animals or is it a combination of b o th? 
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Could the non-screened unlabelled albumin load added by 
Hoffenberg et al (1970) have acted as a carrier of some agent 
or even functioned as a "carbon load" (Freeman et al, 1958)? 
Certainly, more experiments are required to finalise these 
points . 
It seemed a plausible hypothesis to the author that 
the 10-15% value for the liver contribution to total body 
albumin catabolism was an underestimation dictated by the 
functional state of the isolated liver . The enzymes or 
proteolytic mechanisms involved in protein degradation are 
largely unknown (see review of amino acid pools.) Further-
more, Levitan and Webb (1969), Jefferson and Korner (1969) 
and the author of this thesis (part IV) have shown that 
ribosomal disaggregation occurs during perfusion without 
specific amino acid supplements. However, the perfusion studies 
with qualitative and quantitative amino acid supplements shown 
to aggregate both the free and the endoplasmic reticulum- bound 
ribosomes and also to augment albumin synthesis, failed to 
influence the FCRA . This justifies the assumption made in 
Part II and the implication of Kirsch et al (1968) that amino 
acids have no direct influence on albumin catabolism. Further-
more, certainly for short periods, altered protein synthesis is 
not rate limiting to albumin catabolism. 
Reference to the lysosomal system has been made in 
the "Review of Amino Acid Pools". Plasma proteins are thought 
to be engulfed by a process of pinocytosis and then transferred 
in small vesicles to secondary lysosomes . While this process 
ha s been clearly implicated with respect to denatured albumin, 
native albumin degradation is ill-defined. Glucagon induces 
autophagocytosis with participation of lysosomal enzymes 
(Ashford and Porter, 1962; Deter and De Duve, 1967; Guder 
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et al, 1970). Moreover, glucagon increases protein degrada-
tion iri the isolated perfused rat liver (Green and Miller, 1960; 
Miller, 1961). The reciprocal role of insulin and glucagon 
are well established and it was therefore not surprising that 
Mortimore and Mondon (1970) have recently shown that insulin 
can almost completely suppress proteolysis in the isolated 
rat live~. It is therefore very tempting to conclude that 
the lysosomal system and its control are the cornerstone of 
protein, including plasma protein, degradation. 
In vivo, thyroid hormone (Rothschild et al , 1957) 1 
steroid hormones (Rothschild et al, 1958 , Grossman et al, 1960; 
Sterling, 1960) and growth hormone (Kernoff, 1970) have been 
shown to increase the fractional rate of albumin catabolism . 
No effect of these 3 hormones could be shown by the author 
on the FCRA in the isolated perfused rat liver . However , 
insulin retarded albumin degradation . These preliminary 
results raise a number of points :-
(1) Is a system other than the lysosomes involved in catabolism · 
of albumin? Certainly , the in vivo results obtained with 
steroids, the perfusion results with glucagon, the existence 
of other proteolytic enzymes apart from those of the lyso-
somes and the inability to demonstrate the participation of 
lysosomes in the degradation of undenatured albumin suggest 
that this is a strong possibility. 
(2) Is the addition of hormones to an isolated system justifi-
able? Problems in interpretation arise from dose-response 
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relationships, and from the fact that some hormones have been 
shown to require endogenous modification for biological 
activity . 
(3) To what extent does the liver perfusion dictate the 
pattern .of biolog ical activity by virtue· of its isolation? 
This important question aris sin any study.utilising the 
isolated perfused system. There can be little doubt that 
most biological processes are the result of numerous inter-
relating control mechanisms, whether the latter be hormones, 
amino acids, or other factors. Therefore the results 
obtained will, to some extent, depend on the half-life of 
those factors in the perfusion. Hormones provide a prime 
example of this. The system used ,by the author rapidly 
degrades insulin and glucagon but growth hormone, proinsulin 
and parathyroid hormone are relatively resistant (Kelman et 
al, 1971). The net effect would be ' impossible to predict. 
It is possible that while glucagon and insulin degradation 
are balanced, the release of insulin from proinsulin would 
continue to provide an overall "insulin effect". To attempt 
to extrapolate perfusion data to absolute data in vivo is 
dangerous and this certainly applies to the 10-15% estimate 
of albumin catabolism by the liver. 
p A R T IV 
THE EFFECTS OF PERFUSION, AMINO ACIDS AND HORMONES ON 
THE RIBOSOMAL PROFILE OF THE ISOLATED RAT LIVER 
96. 
9 7 / • • 
Introduction . 
The isolated perfused rat liver is widely us ed for 
metaboli c studies. Cri ter ia of adequate function include 
the appearance of the liver, blood and bile flow, glucose 
and urea production, histology, bromsulphthalein excretion 
and incorporation of amino acids into trichloroacetic acid-
precipitable protein. However, analysis of ribosomal 
profiles has revealed that, despite the perfusion meeting 
all of the above criteria, there is a progressive disaggrega-
tion of ribosomes (Levitan and Webb, 1969). The same authors 
have suggested that the change is due to the degradation or 
utilisation of an essential substrate or hormone. Jefferson 
and Korner (1969) found that the presence of arginine, 
asparagine, isoleucin~, leucine, lysine, methionin~, 
phenylalanine, proline, threonine, tryptophan and valine at 
10 times the normal peripheral blood concentration in the 
perfusate prevented this disaggregation. In contrast, 
Rothschild et al (1969c)were able to aggregate the total 
ribosomes of the isolated perfused liver of a fasted rabbit 
97 · 
by adding either tryptophan or isoleucine only to the perfusate. 
It should be noted that Gaetani et al (1969) have shown that 
free and endoplasmic reticulum-bound ribosomes beha.ve different-
ly under certain conditions. They found that on a protein-
free diet, the ffiembrane-bound and free ribosomes of the rat 
liver disaggregate rapidly. Thereafter, there is a 
progressive aggregation of the free ribosomes with maintenance 
of the disaggregation of the endoplasmic reticulum-bound 
r i.bosomes . 
Acco~dingly, the author has investigated the effect of 
amino acids both singly and in combination, not on the total 
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ribosomal profile, but on both free and endoplasmic 
reticulum-bou.nd ribosomal profiles in the isolated perfused 
rat liver. In addition, because of the.widespread influence 
of hormones on protein metabolism, the effects of glucose, 
insulin, cortisone, pancreozymin, secretin, gastrin, growth 
hormone, glucagon and testosterone have been studied . 
~aterials and methods . 
Perfusion apparatus and techniques. 
Liver donors were 320-350 g male Wistar rats housed under 
controlled conditions of temperature, humidity and lighting. 
2 groups of donors were used:-
(1) rats fed ad lib a 20% protein ~iet, and 
(2) rats fasted for 24 hours. 
Both groups had free access to water. Blood was obtained 
by cardiac puncture under diethyl ethe.r anaesthesia fr.om 
well-nourished rats. 42 perfusions were performed according 
to the method of Miller et al (1951) as modified by Fisher 
and Kerly (1964). 
the Appendix . 
The technique is described in detail in 
Amino acids, when added, were L-isomers. They were 
dissolved in the perfusate at the following levels .. 
tryptophan, isoleucine, lysine, alpha-amino isobutyric acid, 
each at 10 micromoles /ml and a combination of arginine, 
asparagine, isoleucine, leucine, lysine, methionine, phenyl-
alani~e, proline, t~reonine, tryptophan and valine each at 
3 or 10 times their normal peripheral plasma concentration, 
depending on the experimental design. The hormones were 
added separately at a concentration of 1 unit of pancreozymin, 
(Boots Pure Drug Co.Ltd., Nottingham, England), 1~ units of 
secretin (Boots Pure Drug Co. Ltd., Nottingham, England), 5 mg 
9 9. 
of gastrin (Peptavl6n. Imperial Chemical Industries Ltd., Cheshire, 
England), 2 units of soluble insulin, B.P. (Boots Pure Drug Co. 
Ltd., Nottingham, England), 2 mg of hydrocortisone (Glaxo-Allenbury' 
S .A., Pty.Ltd.), 2 mg of testosterone propionate (Petersen Ltd., 
Johannesburg) 2 mg of bovine growth hormone and~ mg of glucagon 
(U.S.P. Elli · Lilly & Co., Indianapolis, USA) at the start of the 
perfusion. 
was infused . 
Thereafter, ~ the initial concentration per hour 
Free and bound ribosomal profiles. 
The method of Blobel and Potter (1967) was used to 
isolate free and -bound ribosomes. The principles of the method-
ology have been described. Full details are given in the 
Appendix. After 30 or 150 minutes perfusion, depending upon 
experimental design, the liver was perfused rapidly with 50 ml 
of chilled 0 . 154 molar saline and the ribosomes isolated as 
described in the Appendix. 
livers were used as controls. 
Results 
Non-perfused, anaesthetised rat 
Results have been expressed in a qualitative rather 
than a quantitative · fashion. The "Al" and "A2" pattern 
represent a non-perfused, anaesthetised free and bound profile 
respectively (Figure 12) . The "Bl" and "B2" profiles are 
free and bound profiles respectively after 30 minutes 
perfusion with no supplementation of the perfusate. The 
limitations of the methodology have been discussed previously. 
All groups were handled in the same way and ~t least two perfusions 
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were performed for each group. 
In all profiles the free and bound components behaved 
in the same fashion. 30 minutes of perfusion resulted in the 
B pattern which was accentuated by perfusing for a further 
2 hours. Amino acids added singly were unable to influence 
the B pattern, whether the liver donor was fasted or fed. 
The addition of 3 times th~ peripheral concentration of the 
11 amino acids used by Jefferson and Korner (1969) to the 
perfusate had no effect. Ten times the concentration of these 
11 resulted in the A patter~ both in the free and bound 
profiles. 
B profiles were obtained when glucose, glucose and 
insulin, testosterone, growth hormone, gastrin, .pancreozymin, 
secretin, glucagon or insulin were added to the perfusate. 
Discussion. 
From this work and that of Jefferson and Korner (1969) 
and Levitan and Webb (1969), it is apparent that the ribosomes 
require examination before results from isolated perfused 
organs can be extrapolated to the whole animal. 
Rothschild et al (1969c) found that tryptophan, in 
keeping with its unique role in vivo (Pronczuk et al, 1968; 
Sipransky et al, 1968), aggregated the ribosomes in perfused 
fasted rabbit livers. Howe~er, the author has been unable to 
influence the ribosomal profile with single amino acids using 
livers from either fasted or fed rats. Moreover, an attempt 
to increase amino acid supply with glucagon infusion and 
subsequent addition of tryptophan, as previously described 
in Part II, failed to alter the profile. In contrast, the 
· 101. 
findings of the author support the work of Jefferson and 
Korner (1969) in that arginine, asparagine, isoleucine, 
leucine, lysine, methionine, phenylalanine, proline, threonine, 
tryptophan and valine added to 10 ,times . their normal peripheral 
blood concentration aggregated the ribosomes. The co~cept of 
differential function of free and bound ribosomes has been 
discussed in the "Review of Amino Acid .Pools" and the results 
of the present author suggest that both intracellular and export 
protein are affected . It is difficult to account for the discre-
pancy between the work in the rabbit and the rat. It is 
possible that t~e difference is related t o a difference in the 
dietary habits or in the protein turnover rate of the 2 animals. 
The fact that portal blood c oncentrations of amino 
acids are usually less than 10 times their peripheral concen-
tration even post prandially suggests that other factors are 
involved . In addition, Wittman et al (1969) showed that 
a protein- f'ree diet fed to protein deprived rats was able to 
aggregate the ribosomes . This response was possibly mediated 
by insulin and glucose togeth~r, as they were found to achieve 
the same effect when added instead of the protein- free diet . 
However, in the author's system, glucose and insulin, 
either together or singly , and pancreozymin, secretin, 
growth hormone, . cortisone, testosterone, glucagon and gastrin 
were ineffective. The final common pathway may yet be a 
critical level of amino acid supply with hormones regulating 
amino acid availability by influencing amino acid transport, 
compartmentation, degradative or synthetic pathways or 
protein catabolism. 
102. 
SUMMARY 
' 
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In recent decades, this Medical School has made 
important contributions to the study of clinical malnutrition, 
largely through the work of Professors J.F. Brock and 
J.D.L. Hansen. With .the emergence of Dr. R. Hoffenberg as 
an established investigator in the field of albumin metabolism, 
the laboratory achieved a new dimension. Both Dr. Hoffenberg, 
and later Dr. R.E. Kirsch, made notable contributions to the 
understanding of albumin syn thesis, catabolism and distribu-
tion. Recently Dr. L. Kernoff has expanded the f ield to 
include the role of growth hormone in albumin metabolism . 
Professor S.J. Saunders' expertise in amino acids and interest 
in albumin metabolism provided an active and remarkably topical 
area for research by the author. 
The concept of depressed albumin synthesis rates 
during protein depletion is well established. However , the 
author considers the study in humans to be the first com~>re -
hensive attempt to measure albumin synthesis directly and 
independently of catabolism during controlled conditions of 
protein intake. This study serves to confirm the work of 
Hoffenberg and others, who inferred from their data that 
albumin synthesis is reduced during protein restriction. 
Furthermore, the demonstration that plasma alanine is the 
only amino acid the concentration of which is influenced by 
dietary protein deprivation, is a useful contribution in a 
field with few established facts . Moreoever, few studies 
have included the measurement of tryptophan. The relation-
ship of the low synthesis rate to the elevated plasma 
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alanine levels is felt by the author to be either fortuitous 
or the result of 2 processes acting at different sites. 
However, the possibility of a cause-and-effect relationship 
cannot be excluded. Emphasis has been placed on the complex 
interplay of factors regulating the hepatic intracellular 
amino acid pools and the fact that plasma amino acid levels 
may bear no relation to tissue levels or to protein synthesis 
at other sites. 
Clearly, the accelerated albumin synthesis rates on 
protein loading are related to amino acid supply. However, 
the mechanism has not been established. It was unclear 
whether· the amino acids were only acting as substrate or 
whether their influence was indirect. Furthermore, were 
they equally eff~ctive? 
Perfusion of the isolated rat liver was employed by 
the author to attempt to clarify this issue. The defects 
of the perfusion system used have been emphasised, but 
nonetheless, it remains a powerful tool in the research 
laboratory . From these pe~fusion studies the following 
points relating amino acids to albumin synthesis were 
established:-
(1) It was confirmed that fasting markedly reduces 
albumin synthesis. 
(2) The plasma aminogram is altered by depriving 
rats of protein for 48 hours. 
(3) The use of the above plasma as the perfusate, 
instead of .normal plasma, reduces albumin synthesis 
rates significantly. 
(4) The use of the above perfusate with the 
addition of single amino acids increases 
albumin synthesis rates. 
(5) Single amino acids have no effect on albumin 
synthesis when the liver is derived from 
fasted rats: Yet the addition of 11 amino 
acids added to a concentration of 10 times 
their normal peripheral blood concentration 
restores albumin synthesis to control levels. 
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While the study was in progress, the work of 
Rothschild et al . (1969c) in rabbits was published. Reference 
has been made to the important differences between the studies. 
These include :-
(1) The inability of the author to influence albumin 
synthesis after adding single amino acids to fasted 
livers. The increased synthesis observed by the 
addition of the 11 amino acids demonstrated the 
potential activity of the system. However, even in 
the latter circumstances, no overshoot beyond control 
levels occurred. The postulate that the relatively 
stable mRNA of albumin no longer has to compete with 
more labile mRNA of other proteins for available 
amino acid supply, did not appear to be operative in 
this study. 
(2) Single amino acids including non-essential and non-
metabolisable amino acids increased albumin synthesis 
rates in livers from well nourished rats. 
The work on ribosomes confirmed and extended the 
work of other investigators. The author has demonstrated 
that 
(1) both free and endoplasmic reticulum-bound ribosomes 
disaggregate progressively during
1
per ; usion; 
(2) single amino acids fail to influence the ribosomal 
profile; 
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(3) the 11 amino acids together used by Jefferson and 
Korner (1969) aggregated both populations of ribosomes; 
(4) infusion of growth hormone, cortisone, insulin, 
secretin, gastrin, glucagon and a combination of 
glucose and insulin failed to influence the profiles; 
(5) unlike Rothschild et al (1969c) in the rabbit, the 
author was unable to influence the ribosomal profile 
of fasted rats by the addition of tryptophan or iso-
leucine. However, ribosomal aggregation, like 
accelerated albumin synthesis, still occurred when 
the 11 amino acids were added. 
Bearing in mind the quantitative limitations of the 
technique used by the author, it is unwise to place too much 
emphasis on the association of unchanged ribosomal profiles 
with increased albumin synthesis rates after the addition of 
single amino acids. 
The concept of short-term regulation of protein 
synthesis by dietary tryptophan has not been supported by the 
perfus·ions using fasted livers, possibly as a result of 
insufficient supply of other amino acids. As mentioned above, 
tryptophan together with 10 other amino acids increased albumin 
synthesis and aggregated the ribosomes. The alternative 
method of increasing the supply of other amino acids by 
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infusing glucagon and adding tryptophan was unsuccessful. 
The short study of the influence of amino acids, 
glucagon, insulin, growth hormon~ and hydrocortisone on the 
fractional catabolic rate of albumin represents the only . 
study investigating this control by factors other than 
carbon loading or albumin pool size known to the author. 
A few interesting observations were noted:-
(1) Amino acids do not influence the fractional rate 
of catabolism. 
(2) Accelerated protein synthesis, and thereby possibly 
augmented proteolytic enzyme activity, failed to 
influence the fractional catabolic rate of albumin. 
(3) None of the hormones except insulin had any influence 
on the catabolic rate of albumin. However, insulin 
effected a marginal slowing of catabolism. 
(4) Unlike Hoffenberg et al (1970), normal fractional 
catabolic rates were obtained in the presence of 
low perfusate albumin concentrations. The implica-
tions of this important finding were discussed. 
In summary, it would appear that this thesis consolidates 
and extends existing literature and opens new avenues for 
exploration. 
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A P P E N D I X . 
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A . FRACTIONAT ION OF RAT ALBUMIN 
(1) To 1 volume of plasma add 2 volumes of 0.9% (W/V) sodium 
ch l oride. 
(2) Add 3 volumes of ammonium sulphate solution, saturated 
a t 37°c. 
(3) Allow to stand for 30 mi nutes . Centri f uge to remove 
globulin precipitate. 
( 4 ) Bring supernatant to pH 4.6 with 10 % (V/V) acetic acid. 
(5) Allow to stand for 10 minutes . Centrifuge. 
(6) Dissolve albumin precipitate in distilled water. 
(7) Dialyse overnight against distilled water at 4°c to 
remove residual salt. 
(8) Check (a) concentration of albumin by biuret method. 
(b) purity of fractionation by cellulose acetate 
electrophoresis. 
B. IODINATION . 
Reagents 
(1) Approximately 15 mg human albumin (Sigma Chemical company, 
St. Louis, USA) in Part I and 15 mg rat albumin (prepared 
as described above) in Part III, both contained in 0.5 ml 
volume is used for labelling. 
(2) Iodine monochloride (stock solution) . 
(i) Dissolve 150 mg sodium iodide in 8.0 ml 6N HCl. 
(ii) Dissolve 108 mg sodium iodate monohydrate in 2.0 ml" 
distilled water. 
(iii) Forcibly inject (ii) into (i) to avoid precipitation · 
of iodine. 
(iv) Dilute to 40 .0 ml with distilled water and shake 
with 5.0 ml carbon tetrachloride . 
. 
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The presence of a red discolouration in the organic solvent 
indicates the presence of free iodine. The carbon tetra-
chloride is removed with a pipette, and the extraction 
p~ocess is repeated until the carbon tetrachloride remains 
unchanged in colour . 
(v) Bubble moist air through ICl solution for 
one hour to remove any residual carbon 
tetrachloride. 
(vi) Make up to 45.0 ml with distilled water. 
This solution is stored at 4°c . 
(vii) Before use, dilute l volume of stock 
solution with 9 volumes of 2M NaCl. 
(3) Glycine buffer (stock solution) 
(i) Dissolve 7.5 g glycine in 75.0 ml distilled 
water. 
(ii) Add 25.0 ml lN NaCl . 
( 4) Alkaline glycine buffer (pH. 9. 0-9. 5) . 
Method . 
Add 0.2 ml lN (W/V) NaOH to 1.8 ml of the stock 
solution. 
(a) Prepare alkaline glycine buffer as a.bove · . .. 
(b) Prepare 1.0 ml of a solution bf ICl containing 0.1 ~l. ICl 
with 0.9 ml 2M NaCl. 
(c) Place required amount of radioiodine solution in 0.3 ml 
of the ICl prepared in (b). (Tube A) . 
(d) Adjust pH of albumin solution to 8 . 5 with alkaline 
glycine buffer (Tube B). 
(e) Similarly, bring pH of Tube A to 8 .5. 
(f) Without delay vigorously and only once inject contents 
of Tube A into Tube B. 
(g) Remove the free iodine by dialysis against distilled 
water . 
(h) Check the free radioiodine content on an aliquot of 
the final preparation by trichloroacetic acid precipita-
tion to ensure less than i % free radioiodine for human 
studies and less than 0.02 % for perfusion studies. 
(i) Check that the label is confined only to the albumin 
fraction by cellulose acetate electrophoresis. 
(j) Sterilise by Seitz filtration prior to use in human 
studies. 
C. CATABOLIC RATES IN LIVER PERFUSIONS 
111. 
(1) Prepare the rat albumin by ammonium sulphate precipitation 
until pure preparation is obtained as checked by cellulose 
acetate electrophoresis. 
(2) Iodinate as described. 
(3) Remove the denatured molecules by screening the iodinated 
albumin: inject the preparation into the peritoneal 
cavity of a rat. Bleed the rat 48 hours later. 
(4) Dialyse the above plasma against ' distilled water to remove 
non-protein radioactivity. 
(5) Thirty minutes after true start of the perfusion add a 
volume of the plasma to the reservoi~ to achieve a dose 
of 10-20 microcuries for l3lI or 15-40 microcuries for 
125I. 
(6) Wi thdraw samples at 30 minute intervals for 3 hours. 
(7) Pr epare a protein-free supernatant 
To 1.5 ml of plasma add 1.5 ml of 0.33 mM-NaI and 3.0 ml 
of 20 % (W/V) trichloroacetic acid. Centrifuge. Filter 
the supernatant through small cotton wool pledgets. 
(8) Me ~sure the radioactivity on 0.1 ml · samples 0f whole 
plasma and 2 ml sampl es of t he non- protein super natant . 
Count the samples for two 20 minute periods in a Packard 
Autogamma Spectrometer. 
(9) On linear graph paper plot the fraction of iodide released 
per 30 minutes, expressed as a fraction of the mean total 
protein-bound radioactivity during that period, against 
time. 
(10) Derive the best fitting line using the least mean squares 
method. 
(11) Derive the fractional catabolic rate of albumin from the 
slope of the line. 
D. CATABOLIC RATES IN HUMANS. 
112. 
(1) Prepare the sterilised, labelled hill(lan albumin as described. 
(2) Draw up 80 microcuries of ( 12 5I) albumin in a disposable 
syringe. 
(3) Weigh the full syringe. 
( 4 ) Inject the dose intravenously without withdrawing blood. 
(5) Weigh the empty syringe. 
(6) Take a blood sample with a heparinised tube 10 minutes 
a fter injection. 
(7) Take daily blood samples into heparinised tubes and 
collect 24 hour urine samples from day 2 to day 14. 
(8) Prepare a 1 in 200 solution of the dose to use as a 
standard. 
113. 
(9) Pipette 1 ml of daily plasma sample, 2 ml of daily 
urine sample and 1 ml of the standard and count on a 
Packard Autogamma Spectrometer. 
Calculation. 
(i) Calculate the dose injected (D). 
Step (5) - Step (3) = Volume of dose administered (ml) 
(2) 
( 3) 
( 4) 
= volume of dose x standard Total dose 
(counts/minute) (ml) (counts/min/ml) 
Calculate the percentage of the dose remaining ih the 
plasma on each day regarding the 10 minute sample ( p) 
as 100%. Plot these values on linear graph paper. 
From the graph read o ff the daily average of the 
percentage of the dose in the plasma ( Q) • 
Calculate the fraction of the total dose excreted in 
urine during each 24 hour period (U u = i5. Where U = 
the 
fraction of total dose and u = amount of radioactivity 
excreted per day.) 
(5) The fractional catabolic rate of albumin ' (FCRA) = 
u1 
+ 
u2 
+ 
u3 
Ql Q2 Q3 . . 
n 
where n = number of days of 
first 2 days. 
D (6) The plasma volume (K) = P 
Un 
. . . Qn 
measurement excluding 
(7) Plasma albumin pool (PAP in milligrams) = 
the 
albumin concentration (mg/ml) x plasma volume (ml). 
(8) The absolute albumin catabolic rate (ACR in mg/Kg/day) = 
FCRA x PAP 
100 x patients wt . (Kg) 
Modification for repeat experiment in same patient. 
(1) Sample plasma before injection of second dose. 
residual plasma radioactivity. 
(2) Let P be 10 minute plasma radioactivity. 
Then P X = true 10 minute radioactivity 
Plasma volume (K) = Dose (D) = 10 minute sample 
114. 
Let X be 
therefore "equivalent dose" (injected+ residual activity) 
(3) In calculation (4) above use corrected equivalent dose . 
E. DETERMINATION OF PLASMA ALBUMIN CONCENTRATION. 
Reagents . 
(1) 0.9 % (W/V) NaCl. 
(2) HCl - Ethanol . 
Prepare a mixture of 95 % absolute ethanol and 5% 
methanol. To 600 ml of this ethanol-methanol mixture 
add 1.0 ml of concentrated HCl. Store at 4°c . 
(3) 0.2M. Sodium acetate - ethanol. 
Dissolve 2 . 7218 mg sodium acetate in 5 . 0 ml methanol . 
Add 95 ml absolute ethanol . 
(4) 3% (W/V) sodium hydroxide . 
(5) Biuret reagent. · 
Store at 49c . 
Dissolve (i) 17 . 3 g copper sulphate pentahydrate in 
100 ml hot distilled water. 
(ii) 173 g sodium citrate and 100 g anhydrous 
sodium carbonate in 800 ml distilled water 
while heating. 
When cool, pour (ii) into (i) with rapid stirring . 
Dilute to 1 litre with distilled water. 
(6) ~rotein Standard. 
Method 
30 mg/ml aqueous solution of crystalline human 
albumin. 
(a) To 0.2 ml of plasma add 0.8 ml of 0.9% (W/V) sodium 
chloride . 
(b) Add 9.0 ml HCl-ethanol. Stopper and mix by inversion. 
(c) Incubate for 30 minutes at 37°c. 
(d) Centrifuge. 
115. 
(e) Transfer 5.0 . ml of the supernatant to another centrifuge 
tube. 
(f) Add 0.5 ml of 0.2M acetate-ethanol. Stopper and mix by 
inversion. 
(g) Allow to stand at room temperature for 10 minutes. 
(h) Centrifuge. Pour off supernatant. Invert tubes on 
filter paper to ensure that all supernatant fluid is 
removed. 
(i) Dissolve precipitate in 5.0 ml 3% sodium hydroxide, add 
1.0 ml biuret reagent, and mix. 
(j) Read intensity of colour produced after 15 minutes using 
a 54 filter on a Klett calorimeter. 
A reagent blank consists of 5.0 ml 3% sodium hydroxide 
plus 1.0 ml biuret ' reagent. The known protein standard is 
made by adding 4.9 ml of 3% sodium hydroxide and 1.0 ml 
biuret reagent to 0.1 ml of a 3g% human albumin solution. 
F. MEASUREMENT OF ALBUMIN SYNTHESIS. 
Reagents 
(1) 10% (W/V) and 5 % (W/V) trichloroacetic acid. 
(2) Absolute ethanol. 
(3) co 2-free lN sodium hydroxide . 
(i) Prepare co 2-free water by boiling 200 ml distilled 
wa t e r to half its volume. 
(ii) To 10.0 ml of lON sodium hydroxide add 90 ml co2 -
free water. Stopper tightly and prepare a fresh 
solution for each batch of samples processed. 
(4 ) 4 M citric acid. 
Make 84 g citric acid up to 100 ml volume with distilled 
water . 
(5) Phosp hate buffer (pH 6.7). 
Dissolve 41.75 g sodium pyrophosphate and 5.7. ml 
orthophosphoric acid in 500 ml distilled water. 
(6) Urease solution . 
A 1 mg/ml solution of urease (Nutritional Biochemical 
·corporation, Cleveland, Ohio, USA) in phosphate buffer. 
Store at 40c and renew monthly . 
(7) 10% (W/V) sodium tungstate . 
(8) Tungstic acid . 
Make up 10 .0 ml 10% (W/V) sodium tungstate and 3.8 ml 
l N HCl to 100 ml with distilled water . 
(9) Citric-tungstic acid solution . 
. 
A 1:1 mixture of 4 M citric acid and tungsti c a cid. 
(10) 0 . 66 ~ sulphtiric acid . 
(1 1 ) Resins (Deacidite FF resin is obtained commercially in 
the chloride form - 100-200 mesh; 3.5% cross 
linkage.) 
11 6 . 
A. !:!,Ydroxide form 
(i) Wash the chloride form with distilled water 
until eluate is clear. 
(ii) Wash with 4 litres of 4 N NaOH. 
(iii) Wash with 4 litres of 2 N NaOH. 
(iv) Determine if eluate is free of chloride ions 
by testing with silver nitra,te at acid pH. 
117. 
(v) If necessary repeat washings with 4 N and 2 N 
NaOH ultil eluate is chloride free. 
(vi) Wash with distilled water to pH 7.0. 
B. Carbonate form . 
(i) Wash the hydroxide form with several litres 
of 0.5 N sodium bicarbonate. 
(ii) Wash with distilled water to pH 7.0. 
C. Mixed form 
A 1:1 mixture of chloride and hydroxide form. 
(12) Activated arginase solution. 
Prepare manganese/maleic buffer. 
(i) Dissolve 8.90 g sodium maleate in 200 ml 
distilled water. 
(ii) Bring pH to 9.7-9.8 with l N NaOH. 
(iii) Add 11.5 'g manganese sulphate (Mnso 4 .4H 20) and 
make up to 500 ml with distilled water. 
(iv) Bring to pH 7.0 with l N HCl . 
Arginase solution is prepared as al mg/ml solution of 
arginase (Nutritional Biochemical Corporation) in 
manganese/maleic buffer . Add required amount of arginase 
to the appropriate volume of buffer, and incubate fo~ 3 
hours at 37°c. The solution is stored at 40c and 
118 . 
r enewed e v e ry 2 months. 
(1 3) Phenylethylamine - me t h anol. 
(i) Redistil commercially obtained phenylethylamine until 
yellow colour is r emoved. 
(ii ) Mix with an equal volume of methanol . . 
(iii) Store in the dark . 
(14 ) Scin tillation mixture . 
Method 
Dissolve 7.5 g 2,5-diphenyloxazole (PPO) and 0.75 g 
1,4-bis-(4-methyl-5-phenyloxazole-2-yl) benzene (POPOP) 
in 2.5 litres anhydrous toluene. 
A. Prep aration of ·samples for meas urement of albumin guanidine 
carbon s p ecific activity. 
(1) Extraction of albumin from plasma. 
(i) Human study. 
To 5 ml of plasma add an equal value 
of 10% trichloroacetic acid. 
Perfusion study. 
To 1 ml of plasma add 1 ml of bovine albumin (100 mg/ml 
British D~ug House Chemicals Limited, Poole, England)and 
add 2 ml of 10% trichloroacetic acid. 
(ii) Mix well, centrifuge and discard supernatant. 
(iii) Wamprecipitate with an equal volume of cold 5% 
trich loroacetic acid. Resuspend. Centrifuge and 
discard supernatant. 
(iv) Add 3 volumes of absolute ethanol to precipitate. 
Mi x t h oroughly and centrifuge to remove globulin 
precipitate. 
(v) Dialyse albumin-rich supernatant against distilled 
water overnight at 4°c. 
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(vi)Concentrate sample to approximately 2 ml . Confirm 
homogeneity of fraction by cellulose acetate electro-
phoresis. Measure the volume and concentration by the 
. 
biuret method to give the total amount of albumin 
present. 
(2) Acid hydrolysis of albumin . 
(i) Given that 100 ml of 6 N HCl is added to 250 mg protein, 
determine amount of 6 N HCl required for sample (1 vi). 
(ii) Add volumes of water and concentrated HCl to sample 
so that the final solution is 6 N with respect to HCl . 
(iii)Transfer to hydrolysis tubes and hydrolyse for 16 hours 
at 110-115°c . 
(iv) Transfer the hydrolysate to a round-bottom flask and 
evaporate to dryness. 
(v) Wash dried sample in flask with 3-5 ml distilled water 
and evaporate to dryness again. 
(3) Neutralisation of hydrolysate, and incubation with 
arginase. 
(i) Dissolve amino acid residue in 2-3 ml distilled water. 
(ii) Bring to pH 7.0 by the addition of Deacidite FF resin 
in the carbonate form. 
(iii)Pass through a glass column containing approximately 
5 mm of the carbonate resin. 
(iv) Wash the flask with about 10 ml distilled water and 
add washings to the column. 
(v) Collect eulate in a round-bottom flask. 
If less than 100 mg of albumin was hydrolysed 
(a) add 2 ml activated arginase solution. 
(b) bring to pH 9.0 with ' 1 N NaOH . 
(c) Incubate for 16 hours at 38°c . 
If more than 100 mg of albumin was hydrolysed: 
120. 
(a) Prepare a column (9 by 1 cm) of mixed chloride and 
hydroxide resins. 
water to pH 7 .0. 
(1:1). ' Wash with distilled 
(b) Concentrate eluate (3 v) to approximately 2 ml 
and place on column. 
(c) Wash column with distilled water, collecting 4 ml 
aliquots of the eluate. Collect 6 such aliquots. 
(d) Spot one drop of each aliquot on filter paper 
and dry in a hot oven (~ llOOC). Spray with 
ninhydrin and return to oven until dry~ The 
presence of arginine is indicated by a purple 
spot. 
(e) Place the aliquots containing arginine into a 
round-bottom flask, add 3 ml activated arginase 
solution, adjust to pH 9.0 and incubate as above. 
After incubation 
(vi) Bring sample to pH 2 . 0 with 4 M citric acid . 
(vii)Evapor~te to dryness. 
(viii) Dissolve this urea in 1 ml of distilled water and 
0.5 ml phosphate buffer. Bring to pH 7.0 with co 2-
free 1 N NaOH. 
Sample is now ready for the gas-train. 
121. 
B . Preparation of samplei for 'the measurement of urea carbon SA 
(i) I. Human study 
(a) Normal diet to 1 ml of plasma add 2 ml stable urea 
(1 mg/ml) and 6 parts of water. Precipitate proteins 
by adding~ part of 10% sodium tungstate and~ part of 
0.66 sulphuric acid . 
(b) Low protein diet: to 5 ml of plasma aad 2 ml stable 
urea (1 mg/ml) and 6 parts of water. Precipitate by 
adding~ part of 10% sodium hydroxide and~ part of 
0.66 sulphuric acid. 
( ii) 
Ciii) 
II.Perfusion study. 
To 0.5 ml plasma add 2.0 ml of stable urea (1 mg/ml). 
Precipitate proteins by adding 1.0 ml of 10% sodium · 
tungstate, .and 1.0 ml 0.66 N sulphuric acid. 
Mix well by inversion and leave to stand for 5 minutes. 
Centrifuge. 
Place protein-free supernatant in round-bottom flask and 
evaporate to dryness. 
(iv) Redissolve in 1.0 ml distilled water and 0.5 ml phosphate 
buffer . 
(v) Bring to pH 7:0 with co 6-free 1 N NaOH. 
Sample is now ready f .or the gas-train. 
C. Measurement of 14co 2 Specific Activity (See Figure A:l) 
(i) Place sample in centre bulb of reaction vessel (a). 
Place 1 ml urease in one side-arm and 1 ml citr~c~ 
tungstic acid solution in the other side-arm. 
(ii) Briefly immerse vessel in a solid CO 2-ethanol mixture 
·
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122. 
and evacuate gases present in solution while gently 
thawing . Seal vessel by closing tap. 
(iii) Tip in urease from side-arm and allow to incubate 
for one hour at room temperature. 
(iv) Tip acid mixture into reaction· vessel and shake gently 
to release co 2 . 
(v) Place reaction vessel on gas-train and immerse in solid 
CO 2-ethanol. 
(vi) Evacuate gas line. 
(vii) Immerse cold finger (b) in liquid nitrogen an~ allow 
co 2 to pass from re
action vessel to cold finger. 
(viii) Evacuate any contaminant gases present while the co 2 
sample is trapped under liquid nitrogen in the cold 
finger. 
(ix) Close tap above cold finger. Thaw cold finger in 
warm water and then immerse in solid CO 2-ethanol, 
releasing the co 2 sample but trappi~g an
y contaminant 
gases. 
(x) Fill cuff (c) surrounding manometer arm with liquid 
nitrogen and allow co2 sample to pass fr
om cold finger 
to manometer arm (previousl~ evacuated) by opening 
the intervening taps and closing the pump tap.' 
(xi) Raise mercury column to trap co 2 sample in the 
manometer arm and thaw by adding warm water to the 
cuff. 
(xii) Adjust mercury column to the reference mark on the 
modified MacLeod chamber (d) to obtain the displace-
ment of mercury by CO2. 
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(xiii) Note the scale reading indicated by the height of 
of the mercury column in the manometer side-arm. 
(xiv) Evacuate the rest of the gas-train including the 
tube (e) containing 2 ml of phenylethylamine-
methanol mixture frozen under.liquid nitrogen. 
(xv) Close the pump tap, lower the mercury and transfer 
the CO 2 to the prepared tube (xiv). 
(xvi) Remove the tube and after thawing transfer the 
solution to a counting vial containing 8 ml of the 
PPO-POPOP scintillation mixture. 
Count each sample for two 20 minute periods in a Beckman 
Liquid Scintillation Counter. 
D. Calculation of albumin synthesis rate. 
Human study. 
(1) Urea carbon specific activity measurements. 
(i) Convert volumes of co 2 into mg C by means of a 
standard graph. 
(ii) Calculate SA (expressed as counts per minute/mg C) 
for each of urea samples. 
(iii) Correct these SA measurements for the stable urea 
added.+ 
· (iv~ Plot corrected SA measurement of day 2 on semilog 
graph paper against time. 
(v) By the least mean squares method plot the best 
fitting line through these points. 
(vi) Apply the slope to the 6 hour value obtained from . 
day l of the experiment. 
· (vii) Extrapolate the line back to the Y axis and determine 
urea SA at t 0 • 
(viii) From the slope determine the fractional SR of urea per 
hour. 
NOTE : (1) When repeated studies are made in the same patient 
4-6 weeks later the residual labelled urea is 
negligible . 
* (2) Equal recovery of the stable and labelled urea occurs. 
(2) Albumin guanidine carbon specific activity measurement . 
(i) Calculate albumin SA as in (i) and (ii) above . 
(ii)Correct the SA meaiurement for the added bovine albumin** 
. 
(iii)Determine ~lbumin SA at t 0 by multiplying the observed 
SA at t 6 by the factor derived from the disappear
anc~ 
of the iodinated albumin sample over the 6 hour 
experimental period. 
Then: 
NOTE 
Fractional SR of albumin 
(% IVP/day) 
= 
Fractional SR urea x 24 x albumin SA at t 0 
Urea SA at · t 0 
Absolute SR albumin 
(mg/kg/24 hours) 
= 
FSR albumin x intra-vascular albumin pool (mg) 
~eight in Kg x 100 
(1) When repeated studies are made in the same patient 
4-6 weeks later, allowance must be made for the 
residual (1 4c) albumin. Substract this residual 
activity from the corrected SA (2 ii) before 
proceeding wi~h (2 iii). 
* * (2) Equal recovery of the stable and labelled albumin 
occurs. 
Perfusion study_ 
(1) Urea carbon radioactivity 
(i), (ii) and (iii) as before. 
(iv) Calculate the urea pool in mg C. 
Urea pool in mg C 
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= Perfusate volume (ml) x final urea concentration (fl\g%J· 
500 
where 12 
60 
= factor for converting mg urea to mg C in urea. 
(v) Calculate the total radioactivity incorporated into urea. 
Total radioactivity incorporated into urea 
(counts/min) 
= urea pool 
(mg C) 
x urea SA 
(C/min/mgC) 
(2) Arginine carbon radioactivity. 
(i) and (ii) as before. 
(iii) Calculate the arginine pool in mg C. 
Arginine pool 
(in mg guanidine C) 
= (100-PCV) x perfusate volume x perfusate albumin 
concentration x 5.95 x 12 
17,400 X 100 
Where (1) (100- PCV) x perfusate volume (ml)_ plasma volume (ml) 
100 
(2) PCV = Packed Cell Volume. 
(3) 5.95 X 12 
174 X 100 = 
factor for converting mg albumin to 
mg guanidine carbon of arginine in 
albumin. 
{4) Albumin concentration expressed in mg/ml. 
(iv) Calculate the total radioactivity incorporated into 
arginine . 
Total radioactivity incorporated into arginine 
(counts/min) 
= arg'inine pool 
(mg C) 
x arginine . SA 
(c/min/mg/C) 
(v) Calculate urea synthesis rate . 
Urea synthesis rate (mg/hr) 
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= 
perfusate volume x(post - pre urea concentration 
in m /ml 
2.5 
(vi) Calculate the arginine synthesis rate. 
Arginine synthesis rate (mg/hr) 
= 
radioactivity incorporated into arginine x urea syn-
thesis rate 
radioactivity incorporated into urea 
(vii) Calculate the albumin synthesis rate. 
Albumin synthesis rate (mg/hr) 
= 
arginine synthesis rate X 100 
5.95 
. 
Where 5.95 TI5o = amount of arginine in albumin. 
(viii) Correct the albumin synthesis rate for body weight. ·· 
Corrected albumin synthesis rate 
= 
(mg/hr/300 g) 
. 
albumin synthesis rate x R 
300 
Where R = Rat body weight. 
G. MEASUREMENT OF PLASMA FREE AMINO ACID CONCENTRATIONS. 
Tryptophan 
Reagents . 
(1) 10% T.C . A. ( iced) 
(2) 18% formaldehyae (1:1 with distilled water). 
(3) 5% H2o 2 from 100 volumes of 30% (1:5 with water) . 
(4) L . tryptophan . 
127. 
Note: glassware used should be meticulously decontaminated. 
Method. 
(a) Pipette 0.6 ml heparinised plasma into a 15 ml glass 
centrifuge tube. 
(b) Add 0.2 ml 18% formaldehyde and mix 
(c) Stopper and place in water bath at 100°c for 20 minutes. 
(d) Remove from water bath and add 0.2 ml 5% H2o2 (freshly 
diluted) while the tube is still hot. 
(e) Stopper. Replace in H2o2 bath for a further 20 minutes. 
(f) Cool to room temperature in cold water. 
(g) Run appropriate standards of L-tryptophan and sample 
blanks concurrently. 
(h) Read on a Beckman fluorimeter. 
Other amino acids 
Apparatus : 
(1) Technicon amino acid auto-analyser. 
(2) Column 127 x 0.62 cm. 
(3) Chromobeads type B (Technicon) resin. 
Reagents : 
(1) Ninhydrin 
(i) Dissolve 45 g ninhydrin and 3.375 g hydrindantin in 
4 .5 L of methylcellusolve in a dark bottle. Mix for 
15 minutes . 
(ii) Add 900 ml of sodium acetate buffer (sodium acetate 
656 g, glacial acetic acid 200 ml, water to 2 L) and 
3,600 ml of water to the ninhydrin solution. 
(iii)Nitrogen should .be bubbled through the mixture during 
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mixing and for at least 30 minutes after the addition 
of the water. 
(2) pH 2.875 Buffer . 
(~) Add 14.71 g sodium citrate (0.05M, 0.150 N with 
respect to sodium) 25 ml of 2 N. (standardised) 
NaOH and 5.0 ml of thiodiglycol (Pierce Chemical 
Company) to 900 ml of water . 
(ii) Adjust pH to 2.875 with 6 N HCl and add 10 ml of 
Brij 35 solution (Atlas Chemical Industries Incorp). 
(iii) Make up to 1 L with deionised water. 
(3) pH 3.800 Buffer 
As above but adjust the final pH to 3.800. 
(4) pH 4.700 Buffer 
(i) Dissolve 471.30 g of sodium citrate in 5.4L of water. 
(ii) Adjust pH to 4.7 with 6 N HCl. Add 60 ml Brij 
solution and make up to 6L with deionised water. 
Store all buffers at 4°c and check . their pH immediately 
before use. 
Method : 
(a) Deproteinise plasma by the addition of salicylsulphonic 
acid crystals. Centrifuge. 
(b) Pump 0.2 NaOH through the column for 30 minutes followed 
by sodium citrate buffer pH 2 . 875 for a further 90 minutes. 
(c) Apply 0.5 ml of internal standard (Norleucine 0.1 micro-
moles/ml) and wash down sides of column with 2 ml of 
pH 2 . 875 buffe~. Pump norleucine and buffer into the 
column with nitrogen at 100 pounds per square inch 
(p.s.i.). 
(d) Apply 0.2 - 0.5 ml of supernatant from (a) in the same 
way. 
(e) Fill column ·to the brim with buffer and connect it to the 
autograd . 
(f) Prior to the above fill the 9 chambered autograd with 
buffers as follows 
Chamber 1 
Chamber 2 
Chamber 3 
Chamb~r 4 
Chamber 5 
Chamber 6 
Chamber ' 7 
Chamber 8 
Chamber 9 
75 ml 
75 ml 
75 ml 
75 ml 
40 ml 
35 ml 
6 ml 
9 ml 
60 ml 
75 ml 
75 ml 
75 ml 
pH 2 . 875 buffer 
pH 2.875 buffer 
pH 2 . 875 buffer 
pH 2.875 buffer 
pH 2 . 875 buffer 
pH 3.800 buffer 
pH 2.875 buffer 
pH 3.800 buffer 
pH 4 .700 buffer 
pH 4 .700 buffer 
pH 4 .700 ·buffer 
pH 4.700 buffer 
(g) Turn on autograd pump and stirrer and then pump the 
buffers through the column at 30 ml/hour at 200 p .s. i . 
129 . 
(h) Set temperature of column at 37°c for the first 90 minutes. 
Then reset to 6o0c for the remaining 19 hours of the run . 
(i) Colour development occurs with ninhydrin under nitrogen, 
. 
the amino acids passing through an oil bath at 950c before 
being cooled and entering the flow cuvettes of the 
calorimeter. 
(~) Set calorimeter to read at 440 mp and 570 mp wavelengths. 
(k) Calculate results utilizing the area under each peak 
with the norleucine peak as a standard. 
H. RIBOSOMAL PROFILES . 
Reagents and apparatus . 
( 1) TKM 
130. 
Dissolve 6.0257 g, Tris, 1.864 g KCl and 1.01665 g MgC1 2 
. 6H 2o in 1 litre of wa~er. Bring t
o pH 7.5 with 1 N.HCl. 
(2) For preparation of special sucrose solutions pass a 
solution of 2.3 M-sucrose in TKM through a millipore 
filter (1.2 u) and keep frozen at -20C. 
(a) 2.0 M-sucrose-s 3 medium= 10 ml stock solution and 
1.5 ml s3 
(b) 1.38 M-sucrose-s 3medium = 10 ml stock solution and 
8 ml s3 . 
(3) Prepare linear sucrose gradients (10-40% W/V in TKM), 
(a) Place 15 ml 10% sucrose in TKM in A (Figure A:2). 
, 
(b) Open tap B to allow the sucrose-TKM to reach C. · 
Close tap B. 
(c) Fill C with 15 ml of 40% sucrose in TKM. 
(d) Start the motor D. 
(e) Open tap; E and B together. 
(f) Chill the linear gradient as soon as it is prepared. 
(A) Preparation of RNase inhibitor. 
(i) Decapitate fasted rats. 
(ii) Remove the livers and chilled them in ice-cold 0.25 M 
sucrose in TKM. 
Note: (1) Use only RNase-free sucrose. 
(2) Perform all subsequent steps at 074°c. 
(iii) . Mince the livers with scissors and add 2 volumes of 
0.25 M sucrose in TKM. 
D 
B E 
A C 
Figure A: 2: APPARATUS FOR PREPARATION OF 
LINEAR SUCROSE GRADIENTS 
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(iv) Homogenise the livers with 10 strokes in a Potter-
Elvehjem homogeniser with a Teflon pestle. 
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(v) Prepare a postmitocho~drial supernatant (S 2 ) by centri-
fuging the homogenate in the SS 34 rotor in the refrigerated 
Sorvall centrifuge for 10 minutes at 16,000 rev/min. 
(vi) Spin s 2 in a Spinco 40 rotor for 4 hours at 40,000 rev/min 
to obtain a supernatant fraction s 3 containing RNase 
inhibitor. 
(vii) Store S3 for a maximum of 30 days. 
(B) Preparation of pellets of free ribosomes. (Figure . A:3) 
(i) Control profiles: remove the livers from the control rats 
anaesthetised with diethyl ether. 
Perfusion profiles: stop the perfusion apparatus. 
Perfuse the liver via the portal vein with 50 ml of 0.9 %(W/V) 
sodium chloride). 
(ii) Chill the livers in a sucrose-s 3 medium (9 parts 0.25 M-
sucrose in TKM and 1 part s 3 ). 
' (iii) Mince the livers with scissors and add the sucrose-S 3 
medium to make up to 2 volumes. 
(iv) Prepare s 2 as previously described (A (iv) and (v) ) . 
(v) Layer 4 ml s 2 over a two-layer dis~ontinued sucrose gradient 
with 3 ml 2.0 M-sucrose-s 3 medium at the bottom and '3 m
l 
1.38 M-sucrose-s 3 medium at the top of a Polyallomer tube
. · 
(v~) Centrifuge for 24 hours at 40,000 rev/min in a Spinco 
40 rotor. 
(vii)Store the pellets of free ribosomes at -2ooc.* 
(C) Preparation of pellets of bound ribosomes. 
(i) With a syringe remove and discard the 4 ml above the 1.38 
M-layer in B(vi) . 
. 
(ii) With a syringe remove the 2.0 M-layer containing the rough 
132. 
endoplasmic reticulum. 
(iii) Hol~ing a glass rod in the tube rehomogenise this layer 
gently with a detergent mixture of Triton X-100 (20% W/V) 
and sodium deoxycholate (5% W/V) to give a final concentra-
tion of 4% Triton X - 100 and 1% sodium deoxycholate. 
(iv) Layer this over 3 ml of 2.0 M-sucrose-s 3 medium . 
(v) Spin for 24 hours at 40,000 rev/min in a Spinco 40 rotor. 
(vi) Store the pellets of ribosomes, originally bound to the 
endoplasmic reticulum, at -20°c. ~ 
*NOTE: The profiles gradually undergo changes with storage. 
(D) 
However, it was found that the qualitative change 
after one week is negligible. 
Examination of profiles . 
(i) Resuspend the ribosomal pellet in 2 ml water and 0.2 ml 
s3 by mixing with a glass rod in the tube. 
(ii) Layer the equivalent of 40 optical density units of the 
. 
ribosome s 3 solution over the linear gradient. 
(iii) Spin the gradient for 2. hours in a Spinco SW 25 rotor at 
25,000 rev/min. 
(iv) . Using the apparatus shown in Figure Ai4 
(a) Fill the continuous infusion pump A and the tubinq B 
with 50% sucrose. 
(b) Fit Cover the gradient tube to achieve a tight seal. 
Puncture the bottom of the tube by applying C firmly 
to D. 
(c) Connect tubing E to the flow cuvette. 
(d) Displace the gradient upwards with the 50% sucrose. 
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(e ) Record the profile with an automatically recording D. B . 
Bec kman Spectrophotometer set at an optical density of 
260 u. 
I . LIVER PERFUSION. 
(1 ) Set up the apparatus as shown in Figure A: 5. 
( 2 ) Under ligh t diethyl ether anaesthesia bleed rats by cardiac 
puncture using heparinised syringes. 
(3) Make up the perfusate volume to 87 ml with 
(i) 56 ml whole rat blood. 
(ii)4 ml Heparin (10 mg/ml - Heparin B.P. Boots Pure Drug Co. 
Ltd., Nottingham, England). 
(iii)25 ml Plasmalyte B (Baxter-Saphar Laborato~ies Ltd., 
Johannesburg, South Africa) containing mEq/L sodium 130, 
chloride 109, potassium 4, manganese 3, sodium bicarbonate 
28. 
(iv)2 ml of 4.2% - sodium bicarbonate. 
(4) Pour 77 ml of the perfusate into the reservoir and start the 
apparatus ensuring that the fan, heater, pump, oxygenator, 
humidifier and magnetic stirrer are working satisfactorily. 
(5) Anaesthetise the rat for dissection in a bell ·jar supplied 
with diethyl ether by an Abingdon Vapori s e r . Transfer the 
rat to the dissecting board continuing the anaesthetic. 
( 6 ) Proceed with dissection : 
( i) Ma ke a midline abdominal incision. E~tend the incision 
laterally on both sides near the lower abdomen. Reflect 
flaps o f abdominal wall laterally. 
(i i ) F ree the stomach from the liver using blunt dissection. 
=::;::=::=...~ steam 
.....---------
~ gas 
f 
b 
f t---<-=---+-----, 
a 
r 
p 
Figure A: 5: THE· PERFUSION SYSTEM 
I - liver 
r - reservoir with 
p - pump 
0 - oxygenator 
f - filter 
a - tap 
b - clamp 
h - bile 
r-1!!"----ilE-gas 
magnetic stirrer 
(iii) Locate and cut through the oesophagus in close 
proximity to the diaphragm, allowing the proximal 
portion to retract into the thorax. 
(iv) Inject 5 mg heparin into the spleen. 
(v) Place a ligature loosely around the bile duct. 
134. 
(vi) Incise the bile duct and after cannulation tighten 
the ligature. 
(vii) Tie off the pyl?ric vein at its junction with the 
portal vein. 
(viii) Place a ligature loosely around the portal vein close 
to the hilum of the liver. 
(ix) Clamp the proximal portion of the portal vein. 
(x) Inci~e the portal vein just proximal to the ligature. 
(xi) Cannulate the portal vein. Tie the ligature firmly. 
(xii) Cut the hepatic veins flush with the liver. 
(xiii) Perfuse the liver slowly with warm plasmalyte Bat a 
low pressure. 
(xiv) Rapidly remove the liver manipulating surrounding 
tissues rather than the liver itself. 
(xv) Place the liver on gauze resting on the glass plate. 
(7) Transfer the glass plate to the reservoir. 
(8) Connect the portal vein to the oxygenator and open tap (A). 
(9) . Adjust the overflow clamp (B) to keep the portal pressure 
at 18 cm water. 
(10) Measure the rate of bile production, blood flow and the 
NOTE: 
pH of the perfusate. Adjust the pH with 4.2% sodium 
bicarbonate if required. 
The "ischaemic time" (step 6 (ix) - step 8) is 
approximately 2 minutes. 
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J. STATISTICAL METHODS 
(1) Mean. LX = X n 
L(X - 2 
Standard deviation of the mean. s = 
x) 
n - 1 
(2) Student's t-test. 
t. = 
1 
-2 degrees of . freedom. 
(3) Linear regression analysis (Method of Least Mean Squares) 
The least square line approximating the set of points 
(x 1 ,y1 ) (x2 ,y 2) .•..•.•.•.• (xn,yn), is g
iven by the equation 
y = mx + c where 
m = 
N Lxy (LX) (Ly) and c = ( L y) ( E x 2 ) - ( L x) ( L xy) 
NLx2 (Ex) 2 NI:x2 - (£x)2 
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SUMMARY 
• 
In recent decades, this Medical School has made 
important contributions to the study of clinical malnutrition, 
largely through the work of Professors J.F. Brock and 
J.D.L. Hansen. With the emergence of Dr. R. Hoffenberg as 
an established investigator in the field of a l bumin metabolism, 
the laboratory achieved a new dimension. Both Dr. Hoffenberg, 
and later Dr. _R.E. Kirsch, made notable contributions to the 
understanding of albumin synthesis, catabolism and distribu-
tion. Recently Dr. L. Kernoff has expanded the field to 
include .the role of growth hormone in albumin metabolism. 
Professor S.J. Saunders' expertise in amino acids and interest 
in albumin metabolism provided an active and remarkably topical 
area for research by the author. 
The concept of depressed albumin synthesis rates 
during protein depletion is well established. However, the 
author considers the study in humans to be the first com1_i re-
hensive attempt to measure albumin synthesis directly and 
independently of catabolism during controlled conditions of 
protein intake. This study serves to confirm the work of 
Hoffenberg and others, who inferred from their data that 
albumin synthesis is reduced during protein restriction. 
Furthermore, the demonstration that plasma alanine is the 
only amino acid the concentration of which is influenced by 
dietary protein deprivation, is a useful contribution in a 
field with few established facts. Moreoever, few studies 
have included the measurement of tryptophan. Th e relation-
ship of the low synthes~s rate to the elevated plasma 
A 
• 
• 
• 
alanine levels is felt by the author to be either fortuitous 
or the result of 2 processes acting at differ ent sites. 
However, the possibility of a cause-and-effect relationship 
cannot be · excluded. Emphasis has been placed on the complex 
interplay of factors regulating the hepatic _intracellular 
amino acid pools and the fact that plasma amino acid levels 
may bear no relation to tissue levels or to protein synthesis 
at other sites. 
Clearly, the accelerated albumin synthesis rates on 
protein loading are related to amino acid supply. However, 
the mechanism has not been established. It was unclear 
whether the amino acids were only acting as substrate or 
whether their influence was indirect. Furthermore, were 
they equally effective? 
Perfusion of the isolated rat liver was employed by 
the author to attempt to clarify this issue. The defects 
of the perfusion system used have been . emphasised, but 
nonetheless, it remains a powerful tool in the research 
laboratory. From these perfusion studies the following 
points relating amino acids to albumin synthesis were 
established:-
(1) It was confirmed that fasting markedly reduces 
albumin synthesis. 
(2) The plasma aminogram is altered by depriving 
rats of protein for 48 hours. 
(3) The use of the above plasma as the perfusate, 
instead of normal plasma, reduces albumin synthesis 
rates significantly . 
. ....•. 
• 
• 
• 
• 
• 
(4) The use of the above perfusate with the 
addition of single amino acids ~ncreases 
albumin synthesis rates. 
(5) Single amino acids have no effect on albumin 
synthesis · when the liver is derived from 
fasted rats. Yet the addition of 11 amino 
acids added to a ·concentration of 10 times 
their normal peripheral blood concentration 
restores albumin synthesis to control levels • 
While the study was in progress, the work of 
Rothschild et al (1969c) in rabbits was published. Reference 
has been made to the important differences between the studies. 
These include :-
(1) The inability of the author to influence albumin 
synthesis after adding single amino acids to fasted 
livers. The increased synthesis observed by the 
addition of the 11 amino acids demonstrated the 
potential activity of the system. However, even in 
the latter circumstances, no overshoot beyond control 
levels occurred. The postulate that the relatively 
stable mRNA of albumin no longer has to compete with 
more labile mRNA of other proteins for available 
amino acid supply, did not appear to be operative in 
this study. 
(2) Single amino acids including non-essential and non-
metabolisable amino acids increased albumin synthesis 
rates in livers from well nourished rats. 
The work on ribosomes confirmed and extended the 
work of other investigators . The author has demonstrated 
• 
• 
• 
• • 
r 
• 
that 
(1) both free and endoplasmic reticulum-bound ribosomes 
disaggregate progressively during perfusion; 
(2) single amino acids fail to influence t h e ribosomal 
profile; 
(3) the 11 amino acids together used by Jefferson and 
. 
Korner (1969) aggregated both populations ~f ribosomes; 
(4) infusion of growth hormone, cortisone, insulin, 
secretin, gastrin, glucagon and a combination of 
glucose and insulin failed to influence the profiles; 
(5) unlike Rothschild et al (1969c) in the rabbit, the 
author was unable to influence the ribosomal profile 
of fasted rats by the addition of tryptophan or iso-
leucine. However, ribosomal aggregation, like 
accelerated albumin s ynthesis, still occurred when 
the 11 amino acids were added. 
Bearing in mind the quantitative limitations of the 
technique used by the author, it is unwise to place too much 
emphasis on the association of unchanged ribosomal profiles 
with increased albumin synthesis rates after the addition of 
single amino acids . 
The concept of short-term r~gulation of protein 
synthesis by dietary tryptophan has not been supported by the 
perfusions using fasted livers, possibly as a result of 
insufficient supply of other amino acids. As mentioned above, 
tryptophan together with 10 other amino acids increased albumin 
synthesis and aggregated the ribosomes. The alternative 
method of increasing the supply of other amino acids by 
... 
• 
• 
• 
infusing glucagon and adding tryptophan was unsuccessful. 
The short study of the influence of amino acids, 
glucagon, insulin, growth hormone and hydrocortisone on the 
fractional catabolic rate of albumin represents the only . 
study investigating this control by factors other than 
carbon loading or albumin pool size known to the author. 
A few interesting observations were noted:-
(1) Amino acids do not influence the fractional rate 
of catabolism. 
(2) Accelerated protein synthesis, and thereby possibly 
augmented proteolytic enzyme activity, failed to 
influence the fractional catabolic rate of albumin. 
(3) None of the hormones except insulin had any influence 
on the catabolic rate of albumin. However, insulin 
effected a marginal slowing of catabolism. 
(4) Unlike Hoffenberg et al (1970), normal fractional 
catabolic rates were obtained in the presence of 
low perfusate albumin concentrations. The implica-
tions of this important finding were discussed. 
·*'·' 
In summary, it would appear that this thesis consolidates 
and extends existing literature and opens new avenues for . 
exploration . 
